| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-20 | 2009-09-30 | 13F-HR/A | Janney Montgomery Scott Llc | Institution | 96,560 | Added More | 2,400 | 2.54 % | $4,010,137 | $4,010,137 | $0 | 0.00 % | $0 | | | | | | News Article | History of Janney Montgomery Scott Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-20 | 2009-09-30 | 13F-HR/A | Janus Capital Management Llc | Institution | 2,576,037 | Added More | 1,876,785 | 268.39 % | $106,982,817 | $106,982,817 | $0 | 0.00 % | $0 | | | | | | News Article | History of Janus Capital Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-19 | 2009-09-30 | 13F-HR | Mcmillion Capital Management Inc | Institution | 100 | No Change | 0 | 0 % | $4,147 | $4,153 | $6 | 0.14 % | $0 | | | | | | News Article | History of Mcmillion Capital Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-19 | 2009-09-30 | 13F-HR/A | Rbc Asset Management Inc | Institution | 160 | Added More | 55 | 52.38 % | $6,635 | $6,645 | $10 | 0.14 % | $3 | | | | | | News Article | History of Rbc Asset Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-19 | 2009-09-30 | 13F-HR/A | Royal Bank Of Canada | Institution | 17,415 | Sold Some | -422 | -2.36 % | $722,200 | $723,245 | $1,045 | 0.14 % | $-25 | | | | | | News Article | History of Royal Bank Of Canada Ownership Of Glaxosmithkline Plc |
| 2009-11-18 | 2009-09-30 | 13F-HR/A | Adage Capital Partners Gp Llc | Institution | 179,700 | New Holding | 179,700 | 100 % | $7,502,475 | $7,462,941 | $-39,534 | -0.52 % | $-39,534 | | | | | | News Article | History of Adage Capital Partners Gp Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-18 | 2009-09-30 | 13F-HR | Jane Street Holding Llc | Institution | 78,646 | Sold Some | -438,364 | -84.78 % | $3,283,471 | $3,266,168 | $-17,302 | -0.52 % | $96,440 | | | | | | News Article | History of Jane Street Holding Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-18 | 2009-09-30 | N-Q | Mlig Variable Insurance Trust - Roszellazard International Portfolio | Global Flex Port | 1,210 | Sold Some | -1,385 | -53.37 % | $50,518 | $50,251 | $-266 | -0.52 % | $305 | | | | | | News Article | History of Mlig Variable Insurance Trust - Roszellazard International Portfolio Ownership Of Glaxosmithkline Plc |
| 2009-11-18 | 2009-09-30 | 13F-HR | Royal Bank Of Canada Trust Co Ltd | Institution | 6,715 | No Change | 0 | 0 % | $280,351 | $278,874 | $-1,477 | -0.52 % | $0 | | | | | | News Article | History of Royal Bank Of Canada Trust Co Ltd Ownership Of Glaxosmithkline Plc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Amvescap Plc | Institution | 3,016,095 | Sold Some | -168,284 | -5.28 % | $126,163,254 | $125,258,425 | $-904,829 | -0.71 % | $50,485 | | | | | | News Article | History of Amvescap Plc Ownership Of Glaxosmithkline Plc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Credit Suisse First Boston | Institution | 313,695 | Sold Some | -488,618 | -60.90 % | $13,121,862 | $13,027,753 | $-94,109 | -0.71 % | $146,585 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Glaxosmithkline Plc |
| 2009-11-17 | 2009-09-30 | N-Q | Lincoln National Aggressive Growth Fund Inc - Lvip Ssga International Index Fund | No Data | 97,181 | Added More | 7,824 | 8.75 % | $4,065,081 | $4,035,927 | $-29,154 | -0.71 % | $-2,347 | | | | | | News Article | History of Lincoln National Aggressive Growth Fund Inc - Lvip Ssga International Index Fund Ownership Of Glaxosmithkline Plc |
| 2009-11-17 | 2009-09-30 | N-Q | Lincoln Variable Insurance Products Trust - Growth Fund | Multi-Cap Growth | 144,470 | No Change | 0 | 0 % | $6,043,180 | $5,999,839 | $-43,341 | -0.71 % | $0 | | | | | | News Article | History of Lincoln Variable Insurance Products Trust - Growth Fund Ownership Of Glaxosmithkline Plc |
| 2009-11-17 | 2009-09-30 | N-Q | Lincoln Variable Insurance Products Trust - Lvip Mfs Value Fund | Multi-Cap Value | 114,940 | Added More | 8,740 | 8.22 % | $4,807,940 | $4,773,458 | $-34,482 | -0.71 % | $-2,622 | | | | | | News Article | History of Lincoln Variable Insurance Products Trust - Lvip Mfs Value Fund Ownership Of Glaxosmithkline Plc |
| 2009-11-17 | 2009-09-30 | N-Q | Lincoln Variable Insurance Products Trust - Lvip Mondrian International Value Fund | Multi-Cap Value | 1,139,816 | Sold Some | -74,252 | -6.11 % | $47,678,503 | $47,336,558 | $-341,945 | -0.71 % | $22,276 | | | | | | News Article | History of Lincoln Variable Insurance Products Trust - Lvip Mondrian International Value Fund Ownership Of Glaxosmithkline Plc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Penobscot Investment Management Company Inc | Institution | 6,560 | No Change | 0 | 0 % | $274,405 | $272,437 | $-1,968 | -0.71 % | $0 | | | | | | News Article | History of Penobscot Investment Management Company Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Rathbone Brothers Plc | Institution | 15,919 | Sold Some | -90 | -0.56 % | $665,892 | $661,116 | $-4,776 | -0.71 % | $27 | | | | | | News Article | History of Rathbone Brothers Plc Ownership Of Glaxosmithkline Plc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Sand Hill Advisors Inc | Institution | 77,691 | Sold Some | -15,967 | -17.04 % | $3,249,815 | $3,226,507 | $-23,307 | -0.71 % | $4,790 | | | | | | News Article | History of Sand Hill Advisors Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-17 | 2009-09-30 | N-Q | Wegener Investment Trust - Wegener Investment Trust | Specialty & Misc | | Sold All | -260 | -100 % | | | | -0.71 % | $78 | | | | | | News Article | History of Wegener Investment Trust - Wegener Investment Trust Ownership Of Glaxosmithkline Plc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Wells Fargo And Co | Institution | 9,889,470 | Sold Some | -2,109,520 | -17.58 % | $413,676,530 | $410,709,689 | $-2,966,841 | -0.71 % | $632,856 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Acadia Trust Na | Institution | 94,727 | Sold Some | -1,695 | -1.75 % | $3,969,061 | $3,934,012 | $-35,049 | -0.88 % | $627 | | | | | | News Article | History of Acadia Trust Na Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Alex Brown Investment Management Llc | Institution | 8,577 | No Change | 0 | 0 % | $359,376 | $356,203 | $-3,173 | -0.88 % | $0 | | | | | | News Article | History of Alex Brown Investment Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Alger Fred Management Inc | Institution | 63,900 | Added More | 50,900 | 391.53 % | $2,677,410 | $2,653,767 | $-23,643 | -0.88 % | $-18,833 | | | | | | News Article | History of Alger Fred Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Alpha Equity Management Llc | Institution | 35,900 | New Holding | 35,900 | 100 % | $1,504,210 | $1,490,927 | $-13,283 | -0.88 % | $-13,283 | | | | | | News Article | History of Alpha Equity Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | American International Group Inc | Institution | 3,915 | Sold Some | -36 | -0.91 % | $164,039 | $162,590 | $-1,449 | -0.88 % | $13 | | | | | | News Article | History of American International Group Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ashfield Capital Partners Llc | Institution | 6,456 | Sold Some | -881 | -12.00 % | $270,506 | $268,118 | $-2,389 | -0.88 % | $326 | | | | | | News Article | History of Ashfield Capital Partners Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Balyasny Asset Management Llc | Institution | 49,500 | New Holding | 49,500 | 100 % | $2,074,050 | $2,055,735 | $-18,315 | -0.88 % | $-18,315 | | | | | | News Article | History of Balyasny Asset Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bangor Savings Bank | Institution | 58,163 | Added More | 409 | 0.70 % | $2,437,030 | $2,415,509 | $-21,520 | -0.88 % | $-151 | | | | | | News Article | History of Bangor Savings Bank Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bluestein R H And Co | Institution | 25,000 | Added More | 5,000 | 25.00 % | $1,047,500 | $1,038,250 | $-9,250 | -0.88 % | $-1,850 | | | | | | News Article | History of Bluestein R H And Co Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Brown Brothers Harriman And Co | Institution | 11,485 | Sold Some | -2,984 | -20.62 % | $481,222 | $476,972 | $-4,249 | -0.88 % | $1,104 | | | | | | News Article | History of Brown Brothers Harriman And Co Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Brown Investment Advisory And Trust Co | Institution | 60,433 | Sold Some | -24 | -0.03 % | $2,532,143 | $2,509,782 | $-22,360 | -0.88 % | $9 | | | | | | News Article | History of Brown Investment Advisory And Trust Co Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Capital Guardian Trust Co | Institution | 4,552 | No Change | 0 | 0 % | $190,729 | $189,045 | $-1,684 | -0.88 % | $0 | | | | | | News Article | History of Capital Guardian Trust Co Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Carret Asset Management | Institution | 10,384 | Sold Some | -400 | -3.70 % | $435,090 | $431,248 | $-3,842 | -0.88 % | $148 | | | | | | News Article | History of Carret Asset Management Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Choate Investment Advisors | Institution | 64,965 | Sold Some | -3,075 | -4.51 % | $2,722,034 | $2,697,996 | $-24,037 | -0.88 % | $1,138 | | | | | | News Article | History of Choate Investment Advisors Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Citadel L P | Institution | 7,006 | Sold Some | -44,343 | -86.35 % | $293,551 | $290,959 | $-2,592 | -0.88 % | $16,407 | | | | | | News Article | History of Citadel L P Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Concert Wealth Management Inc | No Data | 2,155 | Added More | 455 | 26.76 % | $90,295 | $89,497 | $-797 | -0.88 % | $-168 | | | | | | News Article | History of Concert Wealth Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Dassori F Davis Jr | Institution | 14,804 | No Change | 0 | 0 % | $620,288 | $614,810 | $-5,477 | -0.88 % | $0 | | | | | | News Article | History of Dassori F Davis Jr Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Eaton Vance Management | Institution | 786,236 | Sold Some | -6,830 | -0.86 % | $32,943,288 | $32,652,381 | $-290,907 | -0.88 % | $2,527 | | | | | | News Article | History of Eaton Vance Management Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Eaton Vance Management | Institution | 786,236 | Added More | 36,612 | 4.88 % | $32,943,288 | $32,652,381 | $-290,907 | -0.88 % | $-13,546 | | | | | | News Article | History of Eaton Vance Management Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Employees Retirement System Of Texas | Institution | 120,000 | No Change | 0 | 0 % | $5,028,000 | $4,983,600 | $-44,400 | -0.88 % | $0 | | | | | | News Article | History of Employees Retirement System Of Texas Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ewt Llc | Institution | | Sold All | -9,520 | -100 % | | | | -0.88 % | $3,522 | | | | | | News Article | History of Ewt Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fifth Third Bancorp | Institution | 83,494 | Sold Some | -4,041 | -4.61 % | $3,498,399 | $3,467,506 | $-30,893 | -0.88 % | $1,495 | | | | | | News Article | History of Fifth Third Bancorp Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Financial Counselors Inc | Institution | 6,800 | Sold Some | -25 | -0.36 % | $284,920 | $282,404 | $-2,516 | -0.88 % | $9 | | | | | | News Article | History of Financial Counselors Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | First National Bank Of Chester County | Institution | 9,923 | Sold Some | -3,510 | -26.12 % | $415,774 | $412,102 | $-3,672 | -0.88 % | $1,299 | | | | | | News Article | History of First National Bank Of Chester County Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fmr Corp | Institution | 86,534 | Added More | 4,976 | 6.10 % | $3,625,775 | $3,593,757 | $-32,018 | -0.88 % | $-1,841 | | | | | | News Article | History of Fmr Corp Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Furgueson Capital Management | Institution | | Sold All | -100 | -100 % | | | | -0.88 % | $37 | | | | | | News Article | History of Furgueson Capital Management Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Galleon Management L P | Institution | | Sold All | -40,000 | -100 % | | | | -0.88 % | $14,800 | | | | | | News Article | History of Galleon Management L P Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | General Re New England Asset Management Inc | Institution | 95,350 | No Change | 0 | 0 % | $3,995,165 | $3,959,886 | $-35,280 | -0.88 % | $0 | | | | | | News Article | History of General Re New England Asset Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Hale And Dorr Capital Management Llc | Institution | 6,470 | Sold Some | -1,158 | -15.18 % | $271,093 | $268,699 | $-2,394 | -0.88 % | $428 | | | | | | News Article | History of Hale And Dorr Capital Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Jensen Investment Management Inc | Institution | 2,135 | No Change | 0 | 0 % | $89,457 | $88,667 | $-790 | -0.88 % | $0 | | | | | | News Article | History of Jensen Investment Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Jesaga Advisers Llc | Institution | 69,500 | New Holding | 69,500 | 100 % | $2,912,050 | $2,886,335 | $-25,715 | -0.88 % | $-25,715 | | | | | | News Article | History of Jesaga Advisers Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Loomis Sayles And Co L P | Institution | 1,100 | No Change | 0 | 0 % | $46,090 | $45,683 | $-407 | -0.88 % | $0 | | | | | | News Article | History of Loomis Sayles And Co L P Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Millennium Management Llc | Institution | 45,684 | Sold Some | -82,768 | -64.43 % | $1,914,160 | $1,897,257 | $-16,903 | -0.88 % | $30,624 | | | | | | News Article | History of Millennium Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Moore Capital Management Lp | Institution | 300,000 | New Holding | 300,000 | 100 % | $12,570,000 | $12,459,000 | $-111,000 | -0.88 % | $-111,000 | | | | | | News Article | History of Moore Capital Management Lp Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 3,794,020 | Added More | 1,402,424 | 58.63 % | $158,969,438 | $157,565,651 | $-1,403,787 | -0.88 % | $-518,897 | | | | | | News Article | History of Morgan Stanley Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Narwhal Capital Management | No Data | 22,700 | No Change | 0 | 0 % | $951,130 | $942,731 | $-8,399 | -0.88 % | $0 | | | | | | News Article | History of Narwhal Capital Management Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | New York State Teachers Retirement System | Institution | 277,100 | New Holding | 277,100 | 100 % | $11,610,490 | $11,507,963 | $-102,527 | -0.88 % | $-102,527 | | | | | | News Article | History of New York State Teachers Retirement System Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Newalliance Bank | Institution | 10,653 | No Change | 0 | 0 % | $446,361 | $442,419 | $-3,942 | -0.88 % | $0 | | | | | | News Article | History of Newalliance Bank Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Co Of Connecticut | Institution | 10,150 | Added More | 300 | 3.04 % | $425,285 | $421,530 | $-3,756 | -0.88 % | $-111 | | | | | | News Article | History of Northern Trust Co Of Connecticut Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 1,352,241 | Added More | 22,094 | 1.66 % | $56,658,898 | $56,158,569 | $-500,329 | -0.88 % | $-8,175 | | | | | | News Article | History of Northern Trust Corp Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Nwq Investment Management Co Llc | Institution | 138,200 | No Change | 0 | 0 % | $5,790,580 | $5,739,446 | $-51,134 | -0.88 % | $0 | | | | | | News Article | History of Nwq Investment Management Co Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Peconic Partners Llc | Institution | 674,900 | New Holding | 674,900 | 100 % | $28,278,310 | $28,028,597 | $-249,713 | -0.88 % | $-249,713 | | | | | | News Article | History of Peconic Partners Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Rafferty Asset Management Llc | Institution | 1,650 | Sold Some | -320 | -16.24 % | $69,135 | $68,525 | $-611 | -0.88 % | $118 | | | | | | News Article | History of Rafferty Asset Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Rbc Dominion Securities Inc | Institution | 127,711 | Added More | 2,116 | 1.68 % | $5,351,091 | $5,303,838 | $-47,253 | -0.88 % | $-783 | | | | | | News Article | History of Rbc Dominion Securities Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Royal Bank Of Canada Investment Management Uk Ltd | Institution | 5,601 | Sold Some | -1,303 | -18.87 % | $234,682 | $232,610 | $-2,072 | -0.88 % | $482 | | | | | | News Article | History of Royal Bank Of Canada Investment Management Uk Ltd Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Sac Capital Advisors Lp | No Data | 20,392 | New Holding | 20,392 | 100 % | $854,425 | $846,880 | $-7,545 | -0.88 % | $-7,545 | | | | | | News Article | History of Sac Capital Advisors Lp Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Shaw D E And Co Inc | Institution | 70,870 | Sold Some | -183,265 | -72.11 % | $2,969,453 | $2,943,231 | $-26,222 | -0.88 % | $67,808 | | | | | | News Article | History of Shaw D E And Co Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Silvercrest Asset Management Group Llc | Institution | 40,995 | No Change | 0 | 0 % | $1,717,691 | $1,702,522 | $-15,168 | -0.88 % | $0 | | | | | | News Article | History of Silvercrest Asset Management Group Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Sonar Capital Management Llc | Institution | | Sold All | -75,000 | -100 % | | | | -0.88 % | $27,750 | | | | | | News Article | History of Sonar Capital Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | State Treasurer State Of Michigan | Institution | 243,800 | No Change | 0 | 0 % | $10,215,220 | $10,125,014 | $-90,206 | -0.88 % | $0 | | | | | | News Article | History of State Treasurer State Of Michigan Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Telemus Investment Management Llc | Institution | 11,190 | Added More | 140 | 1.26 % | $468,861 | $464,721 | $-4,140 | -0.88 % | $-52 | | | | | | News Article | History of Telemus Investment Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Trustco Bank Corp N Y | Institution | 14,298 | Sold Some | -1,550 | -9.78 % | $599,086 | $593,796 | $-5,290 | -0.88 % | $574 | | | | | | News Article | History of Trustco Bank Corp N Y Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Two Sigma Investments Llc | Institution | | Sold All | -51,104 | -100 % | | | | -0.88 % | $18,908 | | | | | | News Article | History of Two Sigma Investments Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ubs Global Asset Management Americas Inc | Institution | 459,259 | New Holding | 459,259 | 100 % | $19,242,952 | $19,073,026 | $-169,926 | -0.88 % | $-169,926 | | | | | | News Article | History of Ubs Global Asset Management Americas Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Us Bancorp De | Institution | 198,960 | Added More | 2,772 | 1.41 % | $8,336,424 | $8,262,809 | $-73,615 | -0.88 % | $-1,026 | | | | | | News Article | History of Us Bancorp De Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Walleye Trading Llc | Institution | | Sold All | -434 | -100 % | | | | -0.88 % | $161 | | | | | | News Article | History of Walleye Trading Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Waters Parkerson And Co Inc | Institution | 172,591 | Added More | 5,114 | 3.05 % | $7,231,563 | $7,167,704 | $-63,859 | -0.88 % | $-1,892 | | | | | | News Article | History of Waters Parkerson And Co Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Weiss Multi-Strategy Advisers Llc | Institution | | Sold All | -12,900 | -100 % | | | | -0.88 % | $4,773 | | | | | | News Article | History of Weiss Multi-Strategy Advisers Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wellington Management Co Llp | Institution | 4,183,481 | Sold Some | -35,800 | -0.84 % | $175,287,854 | $173,739,966 | $-1,547,888 | -0.88 % | $13,246 | | | | | | News Article | History of Wellington Management Co Llp Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wilkinson Ogrady And Co Inc | Institution | 5,088 | New Holding | 5,088 | 100 % | $213,187 | $211,305 | $-1,883 | -0.88 % | $-1,883 | | | | | | News Article | History of Wilkinson Ogrady And Co Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-16 | 2009-06-30 | 13F-HR/A | Brown Brothers Harriman And Co | Institution | 14,469 | Sold Some | -318 | -2.15 % | $606,251 | $600,898 | $-5,354 | -0.88 % | $118 | | | | | | News Article | History of Brown Brothers Harriman And Co Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-11-13 | 13F-HR | Wilmington Trust Co | Institution | 19,132 | Added More | 1,968 | 11.46 % | $792,830 | $794,552 | $1,722 | 0.21 % | $177 | | | | | | News Article | History of Wilmington Trust Co Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-11-13 | 13F-HR | Wilmington Trust Fsb | Institution | 64,973 | Sold Some | -3,046 | -4.47 % | $2,692,481 | $2,698,329 | $5,848 | 0.21 % | $-274 | | | | | | News Article | History of Wilmington Trust Fsb Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-10-31 | 13F-HR | Peak6 Investments L P | Institution | | Sold All | -51,217 | -100 % | | | | 0.21 % | $-4,610 | | | | | | News Article | History of Peak6 Investments L P Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Allied Irish Banks Plc | Institution | 1,320 | No Change | 0 | 0 % | $54,701 | $54,820 | $119 | 0.21 % | $0 | | | | | | News Article | History of Allied Irish Banks Plc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | 22,170 | Sold Some | -466 | -2.05 % | $918,725 | $920,720 | $1,995 | 0.21 % | $-42 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Armstrong Shaw Associates Inc Ct | Institution | 13,656 | No Change | 0 | 0 % | $565,905 | $567,134 | $1,229 | 0.21 % | $0 | | | | | | News Article | History of Armstrong Shaw Associates Inc Ct Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Axa | Institution | 6,785,818 | Sold Some | -468,031 | -6.45 % | $281,204,298 | $281,815,022 | $610,724 | 0.21 % | $-42,123 | | | | | | News Article | History of Axa Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bank Of Texas | No Data | 6,685 | No Change | 0 | 0 % | $277,026 | $277,628 | $602 | 0.21 % | $0 | | | | | | News Article | History of Bank Of Texas Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 97,109 | Added More | 89,007 | 1098.58 % | $4,024,197 | $4,032,937 | $8,740 | 0.21 % | $8,011 | | | | | | News Article | History of Barclays Plc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barrett Associates Inc Ny | Institution | 1,074 | No Change | 0 | 0 % | $44,507 | $44,603 | $97 | 0.21 % | $0 | | | | | | News Article | History of Barrett Associates Inc Ny Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bartlett And Co | Institution | 10,036 | Added More | 6 | 0.05 % | $415,892 | $416,795 | $903 | 0.21 % | $1 | | | | | | News Article | History of Bartlett And Co Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bnp Paribas Arbitrage Sa | Institution | 61,158 | Added More | 47,595 | 350.91 % | $2,534,388 | $2,539,892 | $5,504 | 0.21 % | $4,284 | | | | | | News Article | History of Bnp Paribas Arbitrage Sa Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Boulder Investment Advisers Llc | Institution | 80,000 | No Change | 0 | 0 % | $3,315,200 | $3,322,400 | $7,200 | 0.21 % | $0 | | | | | | News Article | History of Boulder Investment Advisers Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bragg Financial Advisors Inc | Institution | 9,947 | Added More | 3,000 | 43.18 % | $412,204 | $413,099 | $895 | 0.21 % | $270 | | | | | | News Article | History of Bragg Financial Advisors Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Brandywine Asset Management Llc | Institution | 4,800 | No Change | 0 | 0 % | $198,912 | $199,344 | $432 | 0.21 % | $0 | | | | | | News Article | History of Brandywine Asset Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Capital Fund Management S A | Institution | 1,671 | New Holding | 1,671 | 100 % | $69,246 | $69,397 | $150 | 0.21 % | $150 | | | | | | News Article | History of Capital Fund Management S A Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Capital One Financial Corp | Institution | 596 | Sold Some | -349 | -36.93 % | $24,698 | $24,752 | $54 | 0.21 % | $-31 | | | | | | News Article | History of Capital One Financial Corp Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Carlson Capital L P | Institution | 342,900 | Added More | 101,500 | 42.04 % | $14,209,776 | $14,240,637 | $30,861 | 0.21 % | $9,135 | | | | | | News Article | History of Carlson Capital L P Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Caxton Associates Llc | Institution | 5,129 | New Holding | 5,129 | 100 % | $212,546 | $213,007 | $462 | 0.21 % | $462 | | | | | | News Article | History of Caxton Associates Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Clearbridge Advisors Llc | Institution | 296,322 | Sold Some | -8,735 | -2.86 % | $12,279,584 | $12,306,253 | $26,669 | 0.21 % | $-786 | | | | | | News Article | History of Clearbridge Advisors Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Colorado State Bank Trust | Institution | 7,564 | Added More | 1,276 | 20.29 % | $313,452 | $314,133 | $681 | 0.21 % | $115 | | | | | | News Article | History of Colorado State Bank Trust Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Credit Agricole S A | Institution | 120 | No Change | 0 | 0 % | $4,973 | $4,984 | $11 | 0.21 % | $0 | | | | | | News Article | History of Credit Agricole S A Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Delaware Management Business Trust | Institution | 5,314,580 | Sold Some | -301,748 | -5.37 % | $220,236,195 | $220,714,507 | $478,312 | 0.21 % | $-27,157 | | | | | | News Article | History of Delaware Management Business Trust Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Faim Investments Llc | Institution | 5,960 | New Holding | 5,960 | 100 % | $246,982 | $247,519 | $536 | 0.21 % | $536 | | | | | | News Article | History of Faim Investments Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Fairfield Research Corp | Institution | 6,410 | Added More | 5 | 0.07 % | $265,630 | $266,207 | $577 | 0.21 % | $0 | | | | | | News Article | History of Fairfield Research Corp Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | First Investors Management Co Inc | Institution | 58,600 | No Change | 0 | 0 % | $2,428,384 | $2,433,658 | $5,274 | 0.21 % | $0 | | | | | | News Article | History of First Investors Management Co Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | First Mercantile Trust Co | Institution | 10,400 | No Change | 0 | 0 % | $430,976 | $431,912 | $936 | 0.21 % | $0 | | | | | | News Article | History of First Mercantile Trust Co Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | First National Bank Of Omaha | Institution | 20,388 | No Change | 0 | 0 % | $844,879 | $846,714 | $1,835 | 0.21 % | $0 | | | | | | News Article | History of First National Bank Of Omaha Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Gartmore Mutual Fund Capital Trust | Institution | 672 | Sold Some | -20,728 | -96.85 % | $27,848 | $27,908 | $60 | 0.21 % | $-1,866 | | | | | | News Article | History of Gartmore Mutual Fund Capital Trust Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geode Capital Management Llc | Institution | 33,929 | Sold Some | -11,000 | -24.48 % | $1,406,018 | $1,409,071 | $3,054 | 0.21 % | $-990 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Global Currents Investment Management Llc | Institution | 12,002 | Sold Some | -10,275 | -46.12 % | $497,363 | $498,443 | $1,080 | 0.21 % | $-925 | | | | | | News Article | History of Global Currents Investment Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 2,443,394 | Sold Some | -156,891 | -6.03 % | $101,254,247 | $101,474,153 | $219,905 | 0.21 % | $-14,120 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Grove Creek Asset Management | Institution | 348,993 | Sold Some | -23,141 | -6.21 % | $14,462,270 | $14,493,679 | $31,409 | 0.21 % | $-2,083 | | | | | | News Article | History of Grove Creek Asset Management Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Hightower Advisors Llc | No Data | 23,338 | Sold Some | -16,757 | -41.79 % | $967,127 | $969,227 | $2,100 | 0.21 % | $-1,508 | | | | | | News Article | History of Hightower Advisors Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Keybank National Association | Institution | 66,398 | Sold Some | -1,935 | -2.83 % | $2,751,533 | $2,757,509 | $5,976 | 0.21 % | $-174 | | | | | | News Article | History of Keybank National Association Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Knight Capital Group Inc | Institution | | Sold All | -7,163 | -100 % | | | | 0.21 % | $-645 | | | | | | News Article | History of Knight Capital Group Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Labranche And Co Inc | Institution | | Sold All | -50,472 | -100 % | | | | 0.21 % | $-4,542 | | | | | | News Article | History of Labranche And Co Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Legg Mason Investment Counsel Llc | Institution | 13,942 | Sold Some | -250 | -1.76 % | $577,756 | $579,011 | $1,255 | 0.21 % | $-23 | | | | | | News Article | History of Legg Mason Investment Counsel Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Legg Mason Trust Company National Association | Institution | 15,463 | Added More | 1,075 | 7.47 % | $640,787 | $642,178 | $1,392 | 0.21 % | $97 | | | | | | News Article | History of Legg Mason Trust Company National Association Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Logan Capital Management Inc | Institution | 174,357 | Sold Some | -15,776 | -8.29 % | $7,225,354 | $7,241,046 | $15,692 | 0.21 % | $-1,420 | | | | | | News Article | History of Logan Capital Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Managed Account Advisors Llc | Institution | 927,555 | Added More | 656,753 | 242.52 % | $38,437,879 | $38,521,359 | $83,480 | 0.21 % | $59,108 | | | | | | News Article | History of Managed Account Advisors Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Marshall Ilsley Corp | Institution | 34,854 | Sold Some | -1,137 | -3.15 % | $1,444,350 | $1,447,487 | $3,137 | 0.21 % | $-102 | | | | | | News Article | History of Marshall Ilsley Corp Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Mcadams Wright Ragen Inc | No Data | 26,092 | Sold Some | -650 | -2.43 % | $1,081,252 | $1,083,601 | $2,348 | 0.21 % | $-59 | | | | | | News Article | History of Mcadams Wright Ragen Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | N-Q | Met Investors Series Trust - Harris Oakmark International Portfolio | Global Flex Port | 1,864,300 | No Change | 0 | 0 % | $77,256,592 | $77,424,379 | $167,787 | 0.21 % | $0 | | | | | | News Article | History of Met Investors Series Trust - Harris Oakmark International Portfolio Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | N-Q | Met Investors Series Trust - Metamerican Growth Portfolio | Multi-Cap Growth | 157,700 | Added More | 10,060 | 6.81 % | $6,535,088 | $6,549,281 | $14,193 | 0.21 % | $905 | | | | | | News Article | History of Met Investors Series Trust - Metamerican Growth Portfolio Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | N-Q | Met Investors Series Trust - Van Kampen Comstock Portfolio | Specialty & Misc | 146,823 | Added More | 12,500 | 9.30 % | $6,084,345 | $6,097,559 | $13,214 | 0.21 % | $1,125 | | | | | | News Article | History of Met Investors Series Trust - Van Kampen Comstock Portfolio Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Munder Capital Management | Institution | 16,661 | Sold Some | -11,675 | -41.20 % | $690,432 | $691,931 | $1,499 | 0.21 % | $-1,051 | | | | | | News Article | History of Munder Capital Management Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR/A | Natixis | Institution | | Sold All | -25,300 | -100 % | | | | 0.21 % | $-2,277 | | | | | | News Article | History of Natixis Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR/A | Neuberger Berman Group Llc | No Data | 81,443 | Sold Some | -412 | -0.50 % | $3,374,998 | $3,382,328 | $7,330 | 0.21 % | $-37 | | | | | | News Article | History of Neuberger Berman Group Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | New York State Common Retirement Fund | Institution | 45,246 | Sold Some | -1,397 | -2.99 % | $1,874,994 | $1,879,066 | $4,072 | 0.21 % | $-126 | | | | | | News Article | History of New York State Common Retirement Fund Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Northwestern Mutual Wealth Management Co | Institution | 5,972 | Sold Some | -114 | -1.87 % | $247,480 | $248,017 | $537 | 0.21 % | $-10 | | | | | | News Article | History of Northwestern Mutual Wealth Management Co Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Nuveen Hydepark Group Llc | Institution | 10,168 | Sold Some | -782 | -7.14 % | $421,362 | $422,277 | $915 | 0.21 % | $-70 | | | | | | News Article | History of Nuveen Hydepark Group Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Oppenheimer And Co Inc | Institution | 59,317 | Added More | 30,552 | 106.21 % | $2,458,096 | $2,463,435 | $5,339 | 0.21 % | $2,750 | | | | | | News Article | History of Oppenheimer And Co Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Overbrook Management Corp | Institution | 8,350 | No Change | 0 | 0 % | $346,024 | $346,776 | $752 | 0.21 % | $0 | | | | | | News Article | History of Overbrook Management Corp Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Paradigm Asset Management Co Llc | Institution | 6,450 | Sold Some | -300 | -4.44 % | $267,288 | $267,869 | $581 | 0.21 % | $-27 | | | | | | News Article | History of Paradigm Asset Management Co Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Peoples United Financial Inc | Institution | 22,670 | Sold Some | -2,352 | -9.39 % | $939,445 | $941,485 | $2,040 | 0.21 % | $-212 | | | | | | News Article | History of Peoples United Financial Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Plante Moran Financial Advisors Ltd Partnership | Institution | 6,462 | Sold Some | -457 | -6.60 % | $267,785 | $268,367 | $582 | 0.21 % | $-41 | | | | | | News Article | History of Plante Moran Financial Advisors Ltd Partnership Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Price T Rowe Associates Inc | Institution | 2,228,654 | Added More | 31,378 | 1.42 % | $92,355,422 | $92,556,001 | $200,579 | 0.21 % | $2,824 | | | | | | News Article | History of Price T Rowe Associates Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Raymond James And Associates | Institution | 44,752 | Added More | 9,819 | 28.10 % | $1,854,523 | $1,858,551 | $4,028 | 0.21 % | $884 | | | | | | News Article | History of Raymond James And Associates Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Capital Markets Arbitrage S A | Institution | 10,022 | Added More | 4,499 | 81.45 % | $415,312 | $416,214 | $902 | 0.21 % | $405 | | | | | | News Article | History of Rbc Capital Markets Arbitrage S A Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 150,564 | Added More | 16,252 | 12.10 % | $6,239,372 | $6,252,923 | $13,551 | 0.21 % | $1,463 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Private Counsel Inc | Institution | 4,478 | Sold Some | -23 | -0.51 % | $185,568 | $185,971 | $403 | 0.21 % | $-2 | | | | | | News Article | History of Rbc Private Counsel Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Private Counsel Usa Inc | Institution | 3,620 | Added More | 20 | 0.55 % | $150,013 | $150,339 | $326 | 0.21 % | $2 | | | | | | News Article | History of Rbc Private Counsel Usa Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR/A | Reed Conner And Birdwell Llc | Institution | 6,262 | New Holding | 6,262 | 100 % | $259,497 | $260,061 | $564 | 0.21 % | $564 | | | | | | News Article | History of Reed Conner And Birdwell Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Renaissance Technologies Corp | Institution | 28,600 | New Holding | 28,600 | 100 % | $1,185,184 | $1,187,758 | $2,574 | 0.21 % | $2,574 | | | | | | News Article | History of Renaissance Technologies Corp Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR/A | Sarofim Fayez | Institution | 13,537 | Sold Some | -682 | -4.79 % | $560,973 | $562,192 | $1,218 | 0.21 % | $-61 | | | | | | News Article | History of Sarofim Fayez Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Schafer Cullen Capital Management Inc | Institution | 248,303 | Sold Some | -90,296 | -26.66 % | $10,289,676 | $10,312,024 | $22,347 | 0.21 % | $-8,127 | | | | | | News Article | History of Schafer Cullen Capital Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Segall Bryant And Hamill | Institution | 7,132 | Sold Some | -1,050 | -12.83 % | $295,550 | $296,192 | $642 | 0.21 % | $-95 | | | | | | News Article | History of Segall Bryant And Hamill Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Sentinel Asset Management Inc | Institution | | Sold All | -5,500 | -100 % | | | | 0.21 % | $-495 | | | | | | News Article | History of Sentinel Asset Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Sg Americas Securities Llc | Institution | | Sold All | -95,697 | -100 % | | | | 0.21 % | $-8,613 | | | | | | News Article | History of Sg Americas Securities Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Symons Capital Management Inc | Institution | 194,365 | Added More | 5,675 | 3.00 % | $8,054,486 | $8,071,978 | $17,493 | 0.21 % | $511 | | | | | | News Article | History of Symons Capital Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Thompson Siegel And Walmsley Inc | Institution | 7,697 | Added More | 769 | 11.09 % | $318,964 | $319,656 | $693 | 0.21 % | $69 | | | | | | News Article | History of Thompson Siegel And Walmsley Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Tigershark Partners Llc | Institution | | Sold All | -49,989 | -100 % | | | | 0.21 % | $-4,499 | | | | | | News Article | History of Tigershark Partners Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Toronto Dominion Bank | Institution | 43,380 | Sold Some | -175 | -0.40 % | $1,797,667 | $1,801,571 | $3,904 | 0.21 % | $-16 | | | | | | News Article | History of Toronto Dominion Bank Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Tudor Investment Corp Et Al | Institution | | Sold All | -55,150 | -100 % | | | | 0.21 % | $-4,964 | | | | | | News Article | History of Tudor Investment Corp Et Al Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR/A | United Capital Financial Advisersinc | No Data | 14,751 | Added More | 6,493 | 78.62 % | $611,281 | $612,609 | $1,328 | 0.21 % | $584 | | | | | | News Article | History of United Capital Financial Advisersinc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Williams Jones And Associates Inc | Institution | 8,330 | No Change | 0 | 0 % | $345,195 | $345,945 | $750 | 0.21 % | $0 | | | | | | News Article | History of Williams Jones And Associates Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-13 | 2009-06-30 | 13F-HR | Bank Of Texas | No Data | 6,685 | No Compare | | | $277,026 | $277,628 | $602 | 0.21 % | | | | | | | News Article | History of Bank Of Texas Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-10-30 | 13F-HR | Td Asset Management Usa Inc | Institution | | Sold All | -9,685 | -100 % | | | | 0.16 % | $-678 | | | | | | News Article | History of Td Asset Management Usa Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Agf Funds Inc | Institution | 402,799 | Sold Some | -91,530 | -18.51 % | $16,700,047 | $16,728,242 | $28,196 | 0.16 % | $-6,407 | | | | | | News Article | History of Agf Funds Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Allianz Global Investors Of America L P | Institution | 16,688,445 | Sold Some | -991,310 | -5.60 % | $691,902,930 | $693,071,121 | $1,168,191 | 0.16 % | $-69,392 | | | | | | News Article | History of Allianz Global Investors Of America L P Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Arnhold And S Bleichroeder Advisers Llc | Institution | 1 | No Change | 0 | 0 % | $41 | $42 | $0 | 0.16 % | $0 | | | | | | News Article | History of Arnhold And S Bleichroeder Advisers Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Baldwin Brothers Inc | Institution | 1,998 | Sold Some | -500 | -20.01 % | $82,837 | $82,977 | $140 | 0.16 % | $-35 | | | | | | News Article | History of Baldwin Brothers Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bank Of Nova Scotia | Institution | 50,000 | No Change | 0 | 0 % | $2,073,000 | $2,076,500 | $3,500 | 0.16 % | $0 | | | | | | News Article | History of Bank Of Nova Scotia Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 19,307 | Sold Some | -1,028 | -5.05 % | $800,468 | $801,820 | $1,351 | 0.16 % | $-72 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Beddow Capital Management Inc | Institution | 46,260 | Sold Some | -1,250 | -2.63 % | $1,917,940 | $1,921,178 | $3,238 | 0.16 % | $-88 | | | | | | News Article | History of Beddow Capital Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Boston Family Office Llc | Institution | 19,039 | New Holding | 19,039 | 100 % | $789,357 | $790,690 | $1,333 | 0.16 % | $1,333 | | | | | | News Article | History of Boston Family Office Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Boston Trust And Investment Management Co | Institution | 450 | No Change | 0 | 0 % | $18,657 | $18,689 | $32 | 0.16 % | $0 | | | | | | News Article | History of Boston Trust And Investment Management Co Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Brandes Investment Partners Lp | Institution | 7,237,594 | Sold Some | -451,377 | -5.87 % | $300,070,647 | $300,577,279 | $506,632 | 0.16 % | $-31,596 | | | | | | News Article | History of Brandes Investment Partners Lp Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Capital Investment Counsel Inc | No Data | 16,025 | Added More | 100 | 0.62 % | $664,397 | $665,518 | $1,122 | 0.16 % | $7 | | | | | | News Article | History of Capital Investment Counsel Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Causeway Capital Management Llc | Institution | 235 | No Change | 0 | 0 % | $9,743 | $9,760 | $16 | 0.16 % | $0 | | | | | | News Article | History of Causeway Capital Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Claymore Advisors Llc | Institution | 67,209 | Added More | 37,570 | 126.75 % | $2,786,485 | $2,791,190 | $4,705 | 0.16 % | $2,630 | | | | | | News Article | History of Claymore Advisors Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Community Bank System Inc | Institution | 3,641 | No Change | 0 | 0 % | $150,956 | $151,211 | $255 | 0.16 % | $0 | | | | | | News Article | History of Community Bank System Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Corestates Capital Advisors Llc | No Data | 907 | Sold Some | -89 | -8.93 % | $37,604 | $37,668 | $63 | 0.16 % | $-6 | | | | | | News Article | History of Corestates Capital Advisors Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Davidson D A And Co | Institution | 41,069 | Added More | 11,207 | 37.52 % | $1,702,721 | $1,705,596 | $2,875 | 0.16 % | $784 | | | | | | News Article | History of Davidson D A And Co Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Davidson Investment Advisors | Institution | 41,069 | Added More | 38,303 | 1384.77 % | $1,702,721 | $1,705,596 | $2,875 | 0.16 % | $2,681 | | | | | | News Article | History of Davidson Investment Advisors Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Dodge And Cox | Institution | 67,266,971 | Added More | 1,492,942 | 2.26 % | $2,788,888,618 | $2,793,597,306 | $4,708,688 | 0.16 % | $104,506 | | | | | | News Article | History of Dodge And Cox Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Dreman Value Management L L C | Institution | 11,714 | Sold Some | -93 | -0.78 % | $485,662 | $486,482 | $820 | 0.16 % | $-7 | | | | | | News Article | History of Dreman Value Management L L C Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | First Dallas Securities Inc | Institution | 17,088 | No Change | 0 | 0 % | $708,468 | $709,665 | $1,196 | 0.16 % | $0 | | | | | | News Article | History of First Dallas Securities Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | First Quadrant L P | Institution | 64,877 | Added More | 192 | 0.29 % | $2,689,800 | $2,694,342 | $4,541 | 0.16 % | $13 | | | | | | News Article | History of First Quadrant L P Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | First Trust Advisors Lp | Institution | 28,040 | Added More | 3,047 | 12.19 % | $1,162,538 | $1,164,501 | $1,963 | 0.16 % | $213 | | | | | | News Article | History of First Trust Advisors Lp Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Franklin Resources Inc | Institution | 649,045 | Sold Some | -22,794 | -3.39 % | $26,909,406 | $26,954,839 | $45,433 | 0.16 % | $-1,596 | | | | | | News Article | History of Franklin Resources Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Freestone Capital Management Inc | Institution | 8,864 | Added More | 1,013 | 12.90 % | $367,501 | $368,122 | $620 | 0.16 % | $71 | | | | | | News Article | History of Freestone Capital Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Gamco Investors Inc Et Al | Institution | 15,276 | No Change | 0 | 0 % | $633,343 | $634,412 | $1,069 | 0.16 % | $0 | | | | | | News Article | History of Gamco Investors Inc Et Al Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Grandfield And Dodd Llc | Institution | 15,735 | Sold Some | -263 | -1.64 % | $652,373 | $653,475 | $1,101 | 0.16 % | $-18 | | | | | | News Article | History of Grandfield And Dodd Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Great Oaks Capital Management Llc | Institution | 63,170 | Added More | 4,600 | 7.85 % | $2,619,028 | $2,623,450 | $4,422 | 0.16 % | $322 | | | | | | News Article | History of Great Oaks Capital Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Great West Life Assurance Co | Institution | 8,000 | No Change | 0 | 0 % | $331,680 | $332,240 | $560 | 0.16 % | $0 | | | | | | News Article | History of Great West Life Assurance Co Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Gruss And Co Inc | Institution | 547,860 | No Change | 0 | 0 % | $22,714,276 | $22,752,626 | $38,350 | 0.16 % | $0 | | | | | | News Article | History of Gruss And Co Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Hillsdale Investment Management Inc | Institution | 12,500 | Added More | 2,000 | 19.04 % | $518,250 | $519,125 | $875 | 0.16 % | $140 | | | | | | News Article | History of Hillsdale Investment Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Icon Advisers Inc | Institution | 25,570 | New Holding | 25,570 | 100 % | $1,060,132 | $1,061,922 | $1,790 | 0.16 % | $1,790 | | | | | | News Article | History of Icon Advisers Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Ing Investment Management Co | Institution | 14,907 | Added More | 2,786 | 22.98 % | $618,044 | $619,088 | $1,043 | 0.16 % | $195 | | | | | | News Article | History of Ing Investment Management Co Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Ing Investment Management Co | Institution | 27,028 | Added More | 14,907 | 122.98 % | $1,120,581 | $1,122,473 | $1,892 | 0.16 % | $1,043 | | | | | | News Article | History of Ing Investment Management Co Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Johnson Asset Management Inc | Institution | 1,597 | Sold Some | -175,732 | -99.09 % | $66,212 | $66,323 | $112 | 0.16 % | $-12,301 | | | | | | News Article | History of Johnson Asset Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Kbc Group Nv | Institution | 3,720 | Added More | 420 | 12.72 % | $154,231 | $154,492 | $260 | 0.16 % | $29 | | | | | | News Article | History of Kbc Group Nv Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Kcm Investment Advisors | Institution | 17,790 | Added More | 2,048 | 13.00 % | $737,573 | $738,819 | $1,245 | 0.16 % | $143 | | | | | | News Article | History of Kcm Investment Advisors Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Kinetics Asset Management Inc | Institution | 33,673 | Added More | 2,000 | 6.31 % | $1,396,083 | $1,398,440 | $2,357 | 0.16 % | $140 | | | | | | News Article | History of Kinetics Asset Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Letko Brosseau And Associates Inc | Institution | 20,275 | No Change | 0 | 0 % | $840,602 | $842,021 | $1,419 | 0.16 % | $0 | | | | | | News Article | History of Letko Brosseau And Associates Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Levin Capital Strategies L P | Institution | 64,341 | No Change | 0 | 0 % | $2,667,578 | $2,672,082 | $4,504 | 0.16 % | $0 | | | | | | News Article | History of Levin Capital Strategies L P Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Marco Investment Management Llc | Institution | 44 | Added More | 6 | 15.78 % | $1,824 | $1,827 | $3 | 0.16 % | $0 | | | | | | News Article | History of Marco Investment Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mccormack Advisors International | Institution | 5,480 | New Holding | 5,480 | 100 % | $227,201 | $227,584 | $384 | 0.16 % | $384 | | | | | | News Article | History of Mccormack Advisors International Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 915,321 | Added More | 248,808 | 37.32 % | $37,949,209 | $38,013,281 | $64,072 | 0.16 % | $17,417 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | N-Q | Mtb Group Of Funds - Mtb International Equity Fund | International Large-Cap Core | | Sold All | -20,700 | -100 % | | | | 0.16 % | $-1,449 | | | | | | News Article | History of Mtb Group Of Funds - Mtb International Equity Fund Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mycio Wealth Partners Llc | Institution | 423 | Added More | 48 | 12.80 % | $17,538 | $17,567 | $30 | 0.16 % | $3 | | | | | | News Article | History of Mycio Wealth Partners Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | National Rural Electric Cooperative Association | Institution | 1,389,000 | No Change | 0 | 0 % | $57,587,940 | $57,685,170 | $97,230 | 0.16 % | $0 | | | | | | News Article | History of National Rural Electric Cooperative Association Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Oshaughnessy Asset Management Llc | Institution | 233,923 | Sold Some | -262,435 | -52.87 % | $9,698,448 | $9,714,822 | $16,375 | 0.16 % | $-18,370 | | | | | | News Article | History of Oshaughnessy Asset Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 45,491 | Added More | 2,158 | 4.98 % | $1,886,057 | $1,889,241 | $3,184 | 0.16 % | $151 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Inc | Institution | 89,671 | Added More | 28,709 | 47.09 % | $3,717,760 | $3,724,037 | $6,277 | 0.16 % | $2,010 | | | | | | News Article | History of Padco Advisors Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Palisades Investment Partners Llc | Institution | 234,841 | Added More | 300 | 0.12 % | $9,736,508 | $9,752,947 | $16,439 | 0.16 % | $21 | | | | | | News Article | History of Palisades Investment Partners Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Paydenfunds | Institution | 300 | New Holding | 300 | 100 % | $12,438 | $12,459 | $21 | 0.16 % | $21 | | | | | | News Article | History of Paydenfunds Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Placemark Investments Inc | Institution | 266,064 | Sold Some | -10,434 | -3.77 % | $11,031,013 | $11,049,638 | $18,624 | 0.16 % | $-730 | | | | | | News Article | History of Placemark Investments Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Poplar Forest Capital Llc | No Data | 13,656 | No Change | 0 | 0 % | $566,178 | $567,134 | $956 | 0.16 % | $0 | | | | | | News Article | History of Poplar Forest Capital Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Primecap Management Co | Institution | 8,204,754 | Sold Some | -79,300 | -0.95 % | $340,169,101 | $340,743,434 | $574,333 | 0.16 % | $-5,551 | | | | | | News Article | History of Primecap Management Co Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Qa3 Financial Llc | No Data | 1,474 | Added More | 819 | 125.03 % | $61,112 | $61,215 | $103 | 0.16 % | $57 | | | | | | News Article | History of Qa3 Financial Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Raymond James Trust Co | Institution | 19,826 | Sold Some | -470 | -2.31 % | $821,986 | $823,374 | $1,388 | 0.16 % | $-33 | | | | | | News Article | History of Raymond James Trust Co Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Rbc Cees Trustee Ltd | Institution | 18,228,379 | Sold Some | -309,709 | -1.67 % | $755,748,593 | $757,024,580 | $1,275,987 | 0.16 % | $-21,680 | | | | | | News Article | History of Rbc Cees Trustee Ltd Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Rbc Trustee Ltd | Institution | 545 | No Change | 0 | 0 % | $22,596 | $22,634 | $38 | 0.16 % | $0 | | | | | | News Article | History of Rbc Trustee Ltd Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Royal Bank Of Scotland Group Plc | Institution | 15,417 | Sold Some | -181,119 | -92.15 % | $639,189 | $640,268 | $1,079 | 0.16 % | $-12,678 | | | | | | News Article | History of Royal Bank Of Scotland Group Plc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Russell Frank Co | Institution | 77,672 | Sold Some | -8,044 | -9.38 % | $3,220,281 | $3,225,718 | $5,437 | 0.16 % | $-563 | | | | | | News Article | History of Russell Frank Co Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Santa Fe Partners Llc | Institution | 5,647 | New Holding | 5,647 | 100 % | $234,125 | $234,520 | $395 | 0.16 % | $395 | | | | | | News Article | History of Santa Fe Partners Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Signaturefd Llc | No Data | | Sold All | -275 | -100 % | | | | 0.16 % | $-19 | | | | | | News Article | History of Signaturefd Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Sm And R Investments Inc | Institution | 2,800 | No Change | 0 | 0 % | $116,088 | $116,284 | $196 | 0.16 % | $0 | | | | | | News Article | History of Sm And R Investments Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Sovereign Asset Management Corp | Institution | 165 | No Change | 0 | 0 % | $6,841 | $6,852 | $12 | 0.16 % | $0 | | | | | | News Article | History of Sovereign Asset Management Corp Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Ssi Investment Management Inc | Institution | 62 | New Holding | 62 | 100 % | $2,571 | $2,575 | $4 | 0.16 % | $4 | | | | | | News Article | History of Ssi Investment Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | State Farm Mutual Automobile Insurance Co | Institution | 2,276,000 | No Change | 0 | 0 % | $94,362,960 | $94,522,280 | $159,320 | 0.16 % | $0 | | | | | | News Article | History of State Farm Mutual Automobile Insurance Co Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Suntrust Banks Inc | Institution | 102,498 | Sold Some | -19,242 | -15.80 % | $4,249,567 | $4,256,742 | $7,175 | 0.16 % | $-1,347 | | | | | | News Article | History of Suntrust Banks Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | 75,279 | Added More | 22,903 | 43.72 % | $3,121,067 | $3,126,337 | $5,270 | 0.16 % | $1,603 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Tewksbury Capital Management Ltd | Institution | 17,801 | Added More | 10,136 | 132.23 % | $738,029 | $739,276 | $1,246 | 0.16 % | $710 | | | | | | News Article | History of Tewksbury Capital Management Ltd Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Trust Co Of The Ozarks | Institution | 9,028 | Sold Some | -660 | -6.81 % | $374,301 | $374,933 | $632 | 0.16 % | $-46 | | | | | | News Article | History of Trust Co Of The Ozarks Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Ubs Oconnor Llc | Institution | 565,967 | Added More | 59,727 | 11.79 % | $23,464,992 | $23,504,610 | $39,618 | 0.16 % | $4,181 | | | | | | News Article | History of Ubs Oconnor Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Veritable L P | Institution | 13,668 | Added More | 1,100 | 8.75 % | $566,675 | $567,632 | $957 | 0.16 % | $77 | | | | | | News Article | History of Veritable L P Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Voyageur Asset Management Inc | Institution | | Sold All | -75 | -100 % | | | | 0.16 % | $-5 | | | | | | News Article | History of Voyageur Asset Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Wealth Advisors Of Cincinnati Llc | Institution | | Sold All | -35 | -100 % | | | | 0.16 % | $-2 | | | | | | News Article | History of Wealth Advisors Of Cincinnati Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Wm Advisors Inc | Institution | 6,500 | No Change | 0 | 0 % | $269,490 | $269,945 | $455 | 0.16 % | $0 | | | | | | News Article | History of Wm Advisors Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-12 | 2009-09-30 | 13F-HR | World Asset Management Inc | Institution | 346,554 | No Change | 0 | 0 % | $14,368,129 | $14,392,388 | $24,259 | 0.16 % | $0 | | | | | | News Article | History of World Asset Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Aperio Group Llc | Institution | 60,684 | Added More | 4,561 | 8.12 % | $2,509,283 | $2,520,207 | $10,923 | 0.43 % | $821 | | | | | | News Article | History of Aperio Group Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Bahl And Gaynor Inc | Institution | 131,379 | Sold Some | -8,110 | -5.81 % | $5,432,522 | $5,456,170 | $23,648 | 0.43 % | $-1,460 | | | | | | News Article | History of Bahl And Gaynor Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Citigroup Inc | Institution | 834,272 | Sold Some | -379,296 | -31.25 % | $34,497,147 | $34,647,316 | $150,169 | 0.43 % | $-68,273 | | | | | | News Article | History of Citigroup Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Comerica Bank | Institution | 441,489 | Added More | 63,835 | 16.90 % | $18,255,570 | $18,335,038 | $79,468 | 0.43 % | $11,490 | | | | | | News Article | History of Comerica Bank Ownership Of Glaxosmithkline Plc |
| 2009-11-10 | 2009-09-30 | 13F-HR | First National Trust Co | Institution | 2,662 | Sold Some | -116 | -4.17 % | $110,074 | $110,553 | $479 | 0.43 % | $-21 | | | | | | News Article | History of First National Trust Co Ownership Of Glaxosmithkline Plc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Glenmede Trust Co Na | Institution | 232,736 | Sold Some | -14,648 | -5.92 % | $9,623,634 | $9,665,526 | $41,892 | 0.43 % | $-2,637 | | | | | | News Article | History of Glenmede Trust Co Na Ownership Of Glaxosmithkline Plc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Harris Associates L P | Institution | 1,903,924 | Sold Some | -54,700 | -2.79 % | $78,727,257 | $79,069,964 | $342,706 | 0.43 % | $-9,846 | | | | | | News Article | History of Harris Associates L P Ownership Of Glaxosmithkline Plc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Hynes Himmelreich Glennon And Co | Institution | 7,490 | No Change | 0 | 0 % | $309,712 | $311,060 | $1,348 | 0.43 % | $0 | | | | | | News Article | History of Hynes Himmelreich Glennon And Co Ownership Of Glaxosmithkline Plc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Investment Management Of Virginia Llc | Institution | 4,000 | New Holding | 4,000 | 100 % | $165,400 | $166,120 | $720 | 0.43 % | $720 | | | | | | News Article | History of Investment Management Of Virginia Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-10 | 2009-09-30 | 13F-HR | J P Morgan Chase And Co | Institution | 1,508,080 | Sold Some | -2,098,600 | -58.18 % | $62,359,108 | $62,630,562 | $271,454 | 0.43 % | $-377,748 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of Glaxosmithkline Plc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Kimelman And Baird Llc | Institution | 803 | No Change | 0 | 0 % | $33,204 | $33,349 | $145 | 0.43 % | $0 | | | | | | News Article | History of Kimelman And Baird Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Northroad Capital Management Llc | Institution | 462,659 | Sold Some | -19,202 | -3.98 % | $19,130,950 | $19,214,228 | $83,279 | 0.43 % | $-3,456 | | | | | | News Article | History of Northroad Capital Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Osborne Partners Capital Management | Institution | 100 | No Change | 0 | 0 % | $4,135 | $4,153 | $18 | 0.43 % | $0 | | | | | | News Article | History of Osborne Partners Capital Management Ownership Of Glaxosmithkline Plc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Red Granite Advisors Llc | Institution | 550 | No Change | 0 | 0 % | $22,743 | $22,842 | $99 | 0.43 % | $0 | | | | | | News Article | History of Red Granite Advisors Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Sectoral Asset Management Inc | Institution | 278,500 | No Change | 0 | 0 % | $11,515,975 | $11,566,105 | $50,130 | 0.43 % | $0 | | | | | | News Article | History of Sectoral Asset Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Stephens Inc Ar | Institution | 32,935 | Added More | 331 | 1.01 % | $1,361,862 | $1,367,791 | $5,928 | 0.43 % | $60 | | | | | | News Article | History of Stephens Inc Ar Ownership Of Glaxosmithkline Plc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 895,271 | Added More | 35,358 | 4.11 % | $37,019,456 | $37,180,605 | $161,149 | 0.43 % | $6,364 | | | | | | News Article | History of Ubs Ag Ownership Of Glaxosmithkline Plc |
| 2009-11-10 | 2009-09-30 | 13F-HR | United States Steel And Carnegie Pension Fd | Institution | | Sold All | -992,400 | -100 % | | | | 0.43 % | $-178,632 | | | | | | News Article | History of United States Steel And Carnegie Pension Fd Ownership Of Glaxosmithkline Plc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Wetherby Asset Management Inc | Institution | 7,515 | Sold Some | -871 | -10.38 % | $310,745 | $312,098 | $1,353 | 0.43 % | $-157 | | | | | | News Article | History of Wetherby Asset Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Aberdeen Asset Management Plc | Institution | 16,300 | No Change | 0 | 0 % | $674,331 | $676,939 | $2,608 | 0.38 % | $0 | | | | | | News Article | History of Aberdeen Asset Management Plc Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Beacon Trust Co | Institution | 5,838 | Sold Some | -700 | -10.70 % | $241,518 | $242,452 | $934 | 0.38 % | $-112 | | | | | | News Article | History of Beacon Trust Co Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Bradley Foster And Sargent Inc | Institution | 9,440 | Added More | 37 | 0.39 % | $390,533 | $392,043 | $1,510 | 0.38 % | $6 | | | | | | News Article | History of Bradley Foster And Sargent Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Ccm Partners | Institution | 11,988 | No Change | 0 | 0 % | $495,944 | $497,862 | $1,918 | 0.38 % | $0 | | | | | | News Article | History of Ccm Partners Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Clifford Associates Llc | Institution | 13,168 | No Change | 0 | 0 % | $544,760 | $546,867 | $2,107 | 0.38 % | $0 | | | | | | News Article | History of Clifford Associates Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Fca Corp | Institution | 5,532 | No Change | 0 | 0 % | $228,859 | $229,744 | $885 | 0.38 % | $0 | | | | | | News Article | History of Fca Corp Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Federated Investors Inc | Institution | 1,419,426 | Sold Some | -11,639 | -0.81 % | $58,721,654 | $58,948,762 | $227,108 | 0.38 % | $-1,862 | | | | | | News Article | History of Federated Investors Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Howe Barnes Capital Management Inc | Institution | 12,400 | Sold Some | -25 | -0.20 % | $512,988 | $514,972 | $1,984 | 0.38 % | $-4 | | | | | | News Article | History of Howe Barnes Capital Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Icc Capital Management Inc | Institution | 33,325 | Added More | 2,250 | 7.24 % | $1,378,655 | $1,383,987 | $5,332 | 0.38 % | $360 | | | | | | News Article | History of Icc Capital Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Johnson Investment Counsel Inc | Institution | 6,404 | Sold Some | -1,354 | -17.45 % | $264,933 | $265,958 | $1,025 | 0.38 % | $-217 | | | | | | News Article | History of Johnson Investment Counsel Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Kayne Anderson Rudnick Investment Management Llc | Institution | 7,973 | Added More | 110 | 1.39 % | $329,843 | $331,119 | $1,276 | 0.38 % | $18 | | | | | | News Article | History of Kayne Anderson Rudnick Investment Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Klingenstein Fields And Co Llc | Institution | 372,103 | Sold Some | -8,824 | -2.31 % | $15,393,901 | $15,453,438 | $59,536 | 0.38 % | $-1,412 | | | | | | News Article | History of Klingenstein Fields And Co Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Lazard Asset Management Llc | Institution | 3,074,857 | Sold Some | -701,764 | -18.58 % | $127,206,834 | $127,698,811 | $491,977 | 0.38 % | $-112,282 | | | | | | News Article | History of Lazard Asset Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Lee Munder Capital Group Llc | No Data | 6,672 | No Compare | | | $276,021 | $277,088 | $1,068 | 0.38 % | | | | | | | News Article | History of Lee Munder Capital Group Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Lockwood Financial Services Inc | Institution | 16,700 | Added More | 40 | 0.24 % | $690,879 | $693,551 | $2,672 | 0.38 % | $6 | | | | | | News Article | History of Lockwood Financial Services Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Maryland Capital Management Llc | Institution | 6,557 | Added More | 553 | 9.21 % | $271,263 | $272,312 | $1,049 | 0.38 % | $88 | | | | | | News Article | History of Maryland Capital Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Massachusetts Financial Services Co | Institution | 201,398 | Added More | 14,550 | 7.78 % | $8,331,835 | $8,364,059 | $32,224 | 0.38 % | $2,328 | | | | | | News Article | History of Massachusetts Financial Services Co Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Mondrian Investment Partners Ltd | Institution | 108,800 | Sold Some | -2,200 | -1.98 % | $4,501,056 | $4,518,464 | $17,408 | 0.38 % | $-352 | | | | | | News Article | History of Mondrian Investment Partners Ltd Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Monetary Management Group Inc | Institution | 2,625 | New Holding | 2,625 | 100 % | $108,596 | $109,016 | $420 | 0.38 % | $420 | | | | | | News Article | History of Monetary Management Group Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Northstar Asset Management Llc | Institution | 8,530 | No Change | 0 | 0 % | $352,886 | $354,251 | $1,365 | 0.38 % | $0 | | | | | | News Article | History of Northstar Asset Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Rochdale Investment Management Llc | Institution | 8,150 | Sold Some | -1,002 | -10.94 % | $337,166 | $338,470 | $1,304 | 0.38 % | $-160 | | | | | | News Article | History of Rochdale Investment Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Tweedy Browne Co Llc | Institution | 958,220 | Sold Some | -48,262 | -4.79 % | $39,641,561 | $39,794,877 | $153,315 | 0.38 % | $-7,722 | | | | | | News Article | History of Tweedy Browne Co Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Univest Corp Of Pennsylvania | Institution | 46,566 | Sold Some | -2,084 | -4.28 % | $1,926,435 | $1,933,886 | $7,451 | 0.38 % | $-333 | | | | | | News Article | History of Univest Corp Of Pennsylvania Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Valley Forge Asset Management Corp | Institution | 577,830 | Added More | 21,605 | 3.88 % | $23,904,827 | $23,997,280 | $92,453 | 0.38 % | $3,457 | | | | | | News Article | History of Valley Forge Asset Management Corp Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-08-31 | N-CSR | Ishares Inc - Msci Australia | Specialty & Misc | | Sold All | -1,904,623 | -100 % | | | | 0.38 % | $-304,740 | | | | | | News Article | History of Ishares Inc - Msci Australia Ownership Of Glaxosmithkline Plc |
| 2009-11-09 | 2009-08-31 | N-CSR | Purisima Funds - The Purisima Total Return Fund | Specialty & Misc | 74,350 | Sold Some | -13,900 | -15.75 % | $3,075,860 | $3,087,756 | $11,896 | 0.38 % | $-2,224 | | | | | | News Article | History of Purisima Funds - The Purisima Total Return Fund Ownership Of Glaxosmithkline Plc |
| 2009-11-06 | 2009-09-30 | 13F-HR/A | Baird Robert W And Co Inc | Institution | 72,773 | Sold Some | -1,158 | -1.56 % | $2,948,762 | $3,022,263 | $73,501 | 2.49 % | $-1,170 | | | | | | News Article | History of Baird Robert W And Co Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Blair William And Co | Institution | 38,002 | Added More | 1,508 | 4.13 % | $1,539,841 | $1,578,223 | $38,382 | 2.49 % | $1,523 | | | | | | News Article | History of Blair William And Co Ownership Of Glaxosmithkline Plc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Capital Management Corp Va | Institution | 104,289 | Added More | 24,677 | 30.99 % | $4,225,790 | $4,331,122 | $105,332 | 2.49 % | $24,924 | | | | | | News Article | History of Capital Management Corp Va Ownership Of Glaxosmithkline Plc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Davis R M Inc | Institution | 22,298 | Sold Some | -11,585 | -34.19 % | $903,515 | $926,036 | $22,521 | 2.49 % | $-11,701 | | | | | | News Article | History of Davis R M Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Deere And Co | Institution | 18,487 | Added More | 818 | 4.62 % | $749,093 | $767,765 | $18,672 | 2.49 % | $826 | | | | | | News Article | History of Deere And Co Ownership Of Glaxosmithkline Plc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Doolittle And Ganos Investment Counsel Llc | Institution | 3,800 | No Change | 0 | 0 % | $153,976 | $157,814 | $3,838 | 2.49 % | $0 | | | | | | News Article | History of Doolittle And Ganos Investment Counsel Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-06 | 2009-09-30 | 13F-HR/A | Greenleaf Trust | Institution | 80,231 | Added More | 20,661 | 34.68 % | $3,250,960 | $3,331,993 | $81,033 | 2.49 % | $20,868 | | | | | | News Article | History of Greenleaf Trust Ownership Of Glaxosmithkline Plc |
| 2009-11-06 | 2009-09-30 | 13F-HR/A | Greenleaf Trust | Institution | 59,570 | No Change | 0 | 0 % | $2,413,776 | $2,473,942 | $60,166 | 2.49 % | $0 | | | | | | News Article | History of Greenleaf Trust Ownership Of Glaxosmithkline Plc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Marquette Asset Management Inc | Institution | 61,270 | Added More | 7,242 | 13.40 % | $2,482,660 | $2,544,543 | $61,883 | 2.49 % | $7,314 | | | | | | News Article | History of Marquette Asset Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metlife Securities Inc | Institution | 830 | Sold Some | -355 | -29.95 % | $33,632 | $34,470 | $838 | 2.49 % | $-359 | | | | | | News Article | History of Metlife Securities Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Nbt Bank N A | Institution | 77,366 | Sold Some | -1,544 | -1.95 % | $3,134,870 | $3,213,010 | $78,140 | 2.49 % | $-1,559 | | | | | | News Article | History of Nbt Bank N A Ownership Of Glaxosmithkline Plc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pnc Financial Services Group Inc | Institution | 195,912 | Sold Some | -462,260 | -70.23 % | $7,938,354 | $8,136,225 | $197,871 | 2.49 % | $-466,883 | | | | | | News Article | History of Pnc Financial Services Group Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Schwab Charles Investment Management Inc | Institution | 1,969 | New Holding | 1,969 | 100 % | $79,784 | $81,773 | $1,989 | 2.49 % | $1,989 | | | | | | News Article | History of Schwab Charles Investment Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Synovus Financial Corp | Institution | 56,353 | Added More | 23,175 | 69.85 % | $2,283,424 | $2,340,340 | $56,917 | 2.49 % | $23,407 | | | | | | News Article | History of Synovus Financial Corp Ownership Of Glaxosmithkline Plc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Unionbancal Corp | Institution | 142,426 | Sold Some | -17,167 | -10.75 % | $5,771,102 | $5,914,952 | $143,850 | 2.49 % | $-17,339 | | | | | | News Article | History of Unionbancal Corp Ownership Of Glaxosmithkline Plc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Westport Resources Management Inc | Institution | 5,296 | Sold Some | -341 | -6.04 % | $214,594 | $219,943 | $5,349 | 2.49 % | $-344 | | | | | | News Article | History of Westport Resources Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-06 | 2009-08-31 | N-CSR | John Hancock Funds Ii - International Equity Index Fund | Global Flex Port | 120,830 | New Holding | 120,830 | 100 % | $4,896,032 | $5,018,070 | $122,038 | 2.49 % | $122,038 | | | | | | News Article | History of John Hancock Funds Ii - International Equity Index Fund Ownership Of Glaxosmithkline Plc |
| 2009-11-06 | 2009-08-31 | N-CSR | John Hancock Funds Ii - International Value Fund | International Multi-Cap Value | 992,205 | New Holding | 992,205 | 100 % | $40,204,147 | $41,206,274 | $1,002,127 | 2.49 % | $1,002,127 | | | | | | News Article | History of John Hancock Funds Ii - International Value Fund Ownership Of Glaxosmithkline Plc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Bank Of Hawaii | Institution | 50 | No Change | 0 | 0 % | $2,023 | $2,077 | $54 | 2.64 % | $0 | | | | | | News Article | History of Bank Of Hawaii Ownership Of Glaxosmithkline Plc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Davidson And Garrard Inc | Institution | 6,011 | No Change | 0 | 0 % | $243,205 | $249,637 | $6,432 | 2.64 % | $0 | | | | | | News Article | History of Davidson And Garrard Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Fiduciary Services Corp | Institution | 9,423 | Sold Some | -440 | -4.46 % | $381,255 | $391,337 | $10,083 | 2.64 % | $-471 | | | | | | News Article | History of Fiduciary Services Corp Ownership Of Glaxosmithkline Plc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Fixed Income Securities Lp | Institution | 25,123 | Sold Some | -249 | -0.98 % | $1,016,477 | $1,043,358 | $26,882 | 2.64 % | $-266 | | | | | | News Article | History of Fixed Income Securities Lp Ownership Of Glaxosmithkline Plc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Harbour Investment Management Llc | Institution | 45,785 | Added More | 175 | 0.38 % | $1,852,461 | $1,901,451 | $48,990 | 2.64 % | $187 | | | | | | News Article | History of Harbour Investment Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-05 | 2009-09-30 | 13F-HR | High Point Bank And Trust Co | Institution | 13,482 | No Change | 0 | 0 % | $545,482 | $559,907 | $14,426 | 2.64 % | $0 | | | | | | News Article | History of High Point Bank And Trust Co Ownership Of Glaxosmithkline Plc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Holowesko Partners Ltd | Institution | 110,000 | No Change | 0 | 0 % | $4,450,600 | $4,568,300 | $117,700 | 2.64 % | $0 | | | | | | News Article | History of Holowesko Partners Ltd Ownership Of Glaxosmithkline Plc |
| 2009-11-05 | 2009-09-30 | 13F-HR/A | Huntington National Bank | Institution | 79,396 | Sold Some | -8,204 | -9.36 % | $3,212,362 | $3,297,316 | $84,954 | 2.64 % | $-8,778 | | | | | | News Article | History of Huntington National Bank Ownership Of Glaxosmithkline Plc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Insight 2811 Inc | Institution | 7,282 | No Change | 0 | 0 % | $294,630 | $302,421 | $7,792 | 2.64 % | $0 | | | | | | News Article | History of Insight 2811 Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Kornitzer Capital Management Inc | Institution | 151,147 | Added More | 35,008 | 30.14 % | $6,115,408 | $6,277,135 | $161,727 | 2.64 % | $37,459 | | | | | | News Article | History of Kornitzer Capital Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Parametric Portfolio Associates | Institution | 379,028 | Sold Some | -32,617 | -7.92 % | $15,335,473 | $15,741,033 | $405,560 | 2.64 % | $-34,900 | | | | | | News Article | History of Parametric Portfolio Associates Ownership Of Glaxosmithkline Plc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Philadelphia International Advisors Lp | Institution | 924,722 | Sold Some | -1,322 | -0.14 % | $37,414,252 | $38,403,705 | $989,453 | 2.64 % | $-1,415 | | | | | | News Article | History of Philadelphia International Advisors Lp Ownership Of Glaxosmithkline Plc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Profund Advisors Llc | Institution | 71,048 | Added More | 19,090 | 36.74 % | $2,874,602 | $2,950,623 | $76,021 | 2.64 % | $20,426 | | | | | | News Article | History of Profund Advisors Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Stratton Management Co | Institution | 22,557 | Added More | 7 | 0.03 % | $912,656 | $936,792 | $24,136 | 2.64 % | $7 | | | | | | News Article | History of Stratton Management Co Ownership Of Glaxosmithkline Plc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Tal Global Asset Management Inc | Institution | 170,580 | New Holding | 170,580 | 100 % | $6,901,667 | $7,084,187 | $182,521 | 2.64 % | $182,521 | | | | | | News Article | History of Tal Global Asset Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Teacher Retirement System Of Texas | Institution | 160,000 | Sold Some | -13,000 | -7.51 % | $6,473,600 | $6,644,800 | $171,200 | 2.64 % | $-13,910 | | | | | | News Article | History of Teacher Retirement System Of Texas Ownership Of Glaxosmithkline Plc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Value Line Inc | Institution | 11,970 | No Change | 0 | 0 % | $484,306 | $497,114 | $12,808 | 2.64 % | $0 | | | | | | News Article | History of Value Line Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-05 | 2009-08-31 | N-CSR | Alliancebernstein Pooling Portfolios - Alliancebernstein Inflation Protected Securities Portfolio | Specialty & Misc | 301,400 | New Holding | 301,400 | 100 % | $12,194,644 | $12,517,142 | $322,498 | 2.64 % | $322,498 | | | | | | News Article | History of Alliancebernstein Pooling Portfolios - Alliancebernstein Inflation Protected Securities Portfolio Ownership Of Glaxosmithkline Plc |
| 2009-11-05 | 2009-08-31 | N-CSR | Alliancebernstein Pooling Portfolios - Alliancebernstein International Value Portfolio | International Large-Cap Value | 1,240,800 | No Change | 0 | 0 % | $50,202,768 | $51,530,424 | $1,327,656 | 2.64 % | $0 | | | | | | News Article | History of Alliancebernstein Pooling Portfolios - Alliancebernstein International Value Portfolio Ownership Of Glaxosmithkline Plc |
| 2009-11-05 | 2009-08-31 | N-CSR | Claymore Exchange Traded Fund Trust - Claymoreocean Tomo Growth Etf | Multi-Cap Growth | 5,641 | Added More | 687 | 13.86 % | $228,235 | $234,271 | $6,036 | 2.64 % | $735 | | | | | | News Article | History of Claymore Exchange Traded Fund Trust - Claymoreocean Tomo Growth Etf Ownership Of Glaxosmithkline Plc |
| 2009-11-05 | 2009-08-31 | N-CSR | Claymore Exchange Traded Fund Trust - Claymoreocean Tomo Patent Etf | Specialty & Misc | 2,868 | No Change | 0 | 0 % | $116,039 | $119,108 | $3,069 | 2.64 % | $0 | | | | | | News Article | History of Claymore Exchange Traded Fund Trust - Claymoreocean Tomo Patent Etf Ownership Of Glaxosmithkline Plc |
| 2009-11-05 | 2009-08-31 | N-CSR | Claymore Exchange-Traded Fund Trust 2 - Claymore Sp Global Water Etf | Global Flex Port | 764 | No Compare | | | $30,911 | $31,729 | $817 | 2.64 % | | | | | | | News Article | History of Claymore Exchange-Traded Fund Trust 2 - Claymore Sp Global Water Etf Ownership Of Glaxosmithkline Plc |
| 2009-11-05 | 2009-08-31 | N-CSRS | John Hancock Funds Iii - International Allocation Portfolio | Global Flex Port | 4,415,788 | Added More | 1,917,505 | 76.75 % | $178,662,782 | $183,387,676 | $4,724,893 | 2.64 % | $2,051,730 | | | | | | News Article | History of John Hancock Funds Iii - International Allocation Portfolio Ownership Of Glaxosmithkline Plc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Atlas Browninc | Institution | 5,560 | New Holding | 5,560 | 100 % | $224,068 | $230,907 | $6,839 | 3.05 % | $6,839 | | | | | | News Article | History of Atlas Browninc Ownership Of Glaxosmithkline Plc |
| 2009-11-04 | 2009-09-30 | 13F-HR | First Community Bank Trust And Financial Services Divison | Institution | 400 | No Change | 0 | 0 % | $16,120 | $16,612 | $492 | 3.05 % | $0 | | | | | | News Article | History of First Community Bank Trust And Financial Services Divison Ownership Of Glaxosmithkline Plc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Geewax Plus Partners Llc | Institution | | Sold All | -7,300 | -100 % | | | | 3.05 % | $-8,979 | | | | | | News Article | History of Geewax Plus Partners Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Gw Capital Management Incco | Institution | 102,366 | Sold Some | -2,971 | -2.82 % | $4,125,350 | $4,251,260 | $125,910 | 3.05 % | $-3,654 | | | | | | News Article | History of Gw Capital Management Incco Ownership Of Glaxosmithkline Plc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Haverford Trust Co | Institution | 323,807 | New Holding | 323,807 | 100 % | $13,049,422 | $13,447,705 | $398,283 | 3.05 % | $398,283 | | | | | | News Article | History of Haverford Trust Co Ownership Of Glaxosmithkline Plc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Horizon Asset Management Inc Ny | Institution | 164,657 | Sold Some | -5,759 | -3.37 % | $6,635,677 | $6,838,205 | $202,528 | 3.05 % | $-7,084 | | | | | | News Article | History of Horizon Asset Management Inc Ny Ownership Of Glaxosmithkline Plc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Ims Capital Management | Institution | 16,062 | Added More | 6,657 | 70.78 % | $647,299 | $667,055 | $19,756 | 3.05 % | $8,188 | | | | | | News Article | History of Ims Capital Management Ownership Of Glaxosmithkline Plc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Loring Wolcott And Coolidge Fiduciary Advisors | Institution | 9,320 | Sold Some | -675 | -6.75 % | $375,596 | $387,060 | $11,464 | 3.05 % | $-830 | | | | | | News Article | History of Loring Wolcott And Coolidge Fiduciary Advisors Ownership Of Glaxosmithkline Plc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Meyer Handelman Co | Institution | 53,519 | No Change | 0 | 0 % | $2,156,816 | $2,222,644 | $65,828 | 3.05 % | $0 | | | | | | News Article | History of Meyer Handelman Co Ownership Of Glaxosmithkline Plc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Symphony Asset Management Llc | Institution | 14,982 | Sold Some | -257 | -1.68 % | $603,775 | $622,202 | $18,428 | 3.05 % | $-316 | | | | | | News Article | History of Symphony Asset Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Texas Capital Bancshares Inc | Institution | 4,855 | Added More | 350 | 7.76 % | $195,657 | $201,628 | $5,972 | 3.05 % | $431 | | | | | | News Article | History of Texas Capital Bancshares Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Yorktown Management And Research Co Inc | Institution | 6,000 | Sold Some | -2,000 | -25.00 % | $241,800 | $249,180 | $7,380 | 3.05 % | $-2,460 | | | | | | News Article | History of Yorktown Management And Research Co Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-04 | 2009-08-31 | N-CSR | Alliancebernstein Portfolios - Alliancebernstein Wealth Preservation Strategy | Mixed-Asset Target Allocation Conserv | 71,600 | Sold Some | -43,629 | -37.86 % | $2,885,480 | $2,973,548 | $88,068 | 3.05 % | $-53,664 | | | | | | News Article | History of Alliancebernstein Portfolios - Alliancebernstein Wealth Preservation Strategy Ownership Of Glaxosmithkline Plc |
| 2009-11-04 | 2009-08-31 | N-CSRS | Gmo Trust - Gmo Developed World Stock Fund | Specialty & Misc | | Sold All | -291,325 | -100 % | | | | 3.05 % | $-358,330 | | | | | | News Article | History of Gmo Trust - Gmo Developed World Stock Fund Ownership Of Glaxosmithkline Plc |
| 2009-11-04 | 2009-08-31 | N-CSRS | Gmo Trust - Gmo Foreign Fund | Specialty & Misc | | Sold All | -2,465,953 | -100 % | | | | 3.05 % | $-3,033,122 | | | | | | News Article | History of Gmo Trust - Gmo Foreign Fund Ownership Of Glaxosmithkline Plc |
| 2009-11-04 | 2009-08-31 | N-CSRS | Gmo Trust - Gmo International Core Equity Fund | Multi-Cap Core | | Sold All | -8,551,261 | -100 % | | | | 3.05 % | $-10,518,051 | | | | | | News Article | History of Gmo Trust - Gmo International Core Equity Fund Ownership Of Glaxosmithkline Plc |
| 2009-11-04 | 2009-08-31 | N-CSRS | Gmo Trust - Gmo International Growth Equity Fund | Multi-Cap Growth | | Sold All | -6,703,755 | -100 % | | | | 3.05 % | $-8,245,619 | | | | | | News Article | History of Gmo Trust - Gmo International Growth Equity Fund Ownership Of Glaxosmithkline Plc |
| 2009-11-04 | 2009-08-31 | N-CSRS | Gmo Trust - Gmo International Intrinsic Value Fund | Multi-Cap Value | | Sold All | -11,822,504 | -100 % | | | | 3.05 % | $-14,541,680 | | | | | | News Article | History of Gmo Trust - Gmo International Intrinsic Value Fund Ownership Of Glaxosmithkline Plc |
| 2009-11-04 | 2009-08-31 | N-CSRS | Gmo Trust - Gmo Value Fund | Multi-Cap Value | | Sold All | -2,689,047 | -100 % | | | | 3.05 % | $-3,307,528 | | | | | | News Article | History of Gmo Trust - Gmo Value Fund Ownership Of Glaxosmithkline Plc |
| 2009-11-04 | 2009-08-31 | N-CSR | Ssga Funds - Ssga International Stock Selection Fund | International Multi-Cap Core | 1,030,867 | Added More | 518,379 | 101.14 % | $41,543,940 | $42,811,907 | $1,267,966 | 3.05 % | $637,606 | | | | | | News Article | History of Ssga Funds - Ssga International Stock Selection Fund Ownership Of Glaxosmithkline Plc |
| 2009-11-04 | 2008-06-30 | 13F-HR/A | State Farm Mutual Automobile Insurance Co | Institution | 2,276,000 | No Change | 0 | 0 % | $91,722,800 | $94,522,280 | $2,799,480 | 3.05 % | $0 | | | | | | News Article | History of State Farm Mutual Automobile Insurance Co Ownership Of Glaxosmithkline Plc |
| 2009-11-03 | 2009-09-30 | 13F-HR/A | Cohen Klingenstein Llc | No Data | 98,230 | No Change | 0 | 0 % | $3,972,421 | $4,079,492 | $107,071 | 2.69 % | $0 | | | | | | News Article | History of Cohen Klingenstein Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Eagle Global Advisors Llc | Institution | 476,256 | Added More | 22,902 | 5.05 % | $19,259,793 | $19,778,912 | $519,119 | 2.69 % | $24,963 | | | | | | News Article | History of Eagle Global Advisors Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Ixis Asset Management Advisors L P | Institution | 139,829 | Sold Some | -6,290 | -4.30 % | $5,654,685 | $5,807,098 | $152,414 | 2.69 % | $-6,856 | | | | | | News Article | History of Ixis Asset Management Advisors L P Ownership Of Glaxosmithkline Plc |
| 2009-11-03 | 2009-09-30 | 13F-HR | King Luther Capital Management Corp | Institution | 21,690 | Sold Some | -1,000 | -4.40 % | $877,144 | $900,786 | $23,642 | 2.69 % | $-1,090 | | | | | | News Article | History of King Luther Capital Management Corp Ownership Of Glaxosmithkline Plc |
| 2009-11-03 | 2009-09-30 | 13F-HR | M And T Bank Corp | Institution | 55,146 | Sold Some | -1,219 | -2.16 % | $2,230,104 | $2,290,213 | $60,109 | 2.69 % | $-1,329 | | | | | | News Article | History of M And T Bank Corp Ownership Of Glaxosmithkline Plc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Ntv Asset Management Llc | Institution | 11,387 | No Change | 0 | 0 % | $460,490 | $472,902 | $12,412 | 2.69 % | $0 | | | | | | News Article | History of Ntv Asset Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Private Trust Co Na | Institution | | Sold All | -2,843 | -100 % | | | | 2.69 % | $-3,099 | | | | | | News Article | History of Private Trust Co Na Ownership Of Glaxosmithkline Plc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Prudential Financial Inc | Institution | 26,624 | Sold Some | -8,294 | -23.75 % | $1,076,675 | $1,105,695 | $29,020 | 2.69 % | $-9,040 | | | | | | News Article | History of Prudential Financial Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Rmb Capital Management Llc | Institution | 42,385 | Added More | 4,637 | 12.28 % | $1,714,049 | $1,760,249 | $46,200 | 2.69 % | $5,054 | | | | | | News Article | History of Rmb Capital Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-03 | 2009-08-31 | N-CSR | California Investment Trust - Equity Income Fund | Equity Income | 11,988 | New Holding | 11,988 | 100 % | $484,795 | $497,862 | $13,067 | 2.69 % | $13,067 | | | | | | News Article | History of California Investment Trust - Equity Income Fund Ownership Of Glaxosmithkline Plc |
| 2009-11-03 | 2009-08-31 | N-CSRS | Wells Fargo Funds Trust - Money Market Fund | Specialty & Misc | 152,513 | Sold Some | -182,205 | -54.43 % | $6,167,626 | $6,333,865 | $166,239 | 2.69 % | $-198,603 | | | | | | News Article | History of Wells Fargo Funds Trust - Money Market Fund Ownership Of Glaxosmithkline Plc |
| 2009-11-03 | 2009-06-30 | 13F-HR/A | Cohen Klingenstein Llc | No Data | 98,230 | No Change | 0 | 0 % | $3,972,421 | $4,079,492 | $107,071 | 2.69 % | $0 | | | | | | News Article | History of Cohen Klingenstein Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Bbva Usa Bancshares Inc | Institution | 43,970 | Added More | 5,045 | 12.96 % | $1,790,019 | $1,826,074 | $36,055 | 2.01 % | $4,137 | | | | | | News Article | History of Bbva Usa Bancshares Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Bryn Mawr Trust Co | Institution | 70,261 | No Change | 0 | 0 % | $2,860,325 | $2,917,939 | $57,614 | 2.01 % | $0 | | | | | | News Article | History of Bryn Mawr Trust Co Ownership Of Glaxosmithkline Plc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Citizens Bank Wealth Management Na | Institution | 1,779 | Sold Some | -683 | -27.74 % | $72,423 | $73,882 | $1,459 | 2.01 % | $-560 | | | | | | News Article | History of Citizens Bank Wealth Management Na Ownership Of Glaxosmithkline Plc |
| 2009-11-02 | 2009-09-30 | 13F-HR | First New York Securities Llc | Institution | | Sold All | -13,650 | -100 % | | | | 2.01 % | $-11,193 | | | | | | News Article | History of First New York Securities Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Fny Managed Accounts Llc | Institution | 6,697 | New Holding | 6,697 | 100 % | $272,635 | $278,126 | $5,492 | 2.01 % | $5,492 | | | | | | News Article | History of Fny Managed Accounts Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Ghp Investment Advisors Inc | Institution | | Sold All | -34 | -100 % | | | | 2.01 % | $-28 | | | | | | News Article | History of Ghp Investment Advisors Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Hussman Econometrics Advisors Inc | Institution | | Sold All | -280,000 | -100 % | | | | 2.01 % | $-229,600 | | | | | | News Article | History of Hussman Econometrics Advisors Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Lane Douglas C And Associates Inc | Institution | 5,173 | New Holding | 5,173 | 100 % | $210,593 | $214,835 | $4,242 | 2.01 % | $4,242 | | | | | | News Article | History of Lane Douglas C And Associates Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Lpl Financial Corp | Institution | 13,775 | New Holding | 13,775 | 100 % | $560,780 | $572,076 | $11,296 | 2.01 % | $11,296 | | | | | | News Article | History of Lpl Financial Corp Ownership Of Glaxosmithkline Plc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Montag A And Associates Inc | Institution | 5,853 | Sold Some | -2,048 | -25.92 % | $238,276 | $243,075 | $4,799 | 2.01 % | $-1,679 | | | | | | News Article | History of Montag A And Associates Inc Ownership Of Glaxosmithkline Plc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Oechsle International Advisors Llc | Institution | 184,409 | Added More | 206 | 0.11 % | $7,507,290 | $7,658,506 | $151,215 | 2.01 % | $169 | | | | | | News Article | History of Oechsle International Advisors Llc Ownership Of Glaxosmithkline Plc |
| 2009-11-02 | 2009-09-30 | 13F-HR/A | Penn Mutual Life Insurance Co | Institution | 39,795 | Added More | 1,110 | 2.86 % | $1,620,054 | $1,652,686 | $32,632 | 2.01 % | $910 | | | | | | News Article | History of Penn Mutual Life Insurance Co Ownership Of Glaxosmithkline Plc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Wells Fargo Master Trust - Diversified Stock Portfolio | Flexible Portfolio | 152,513 | No Change | 0 | 0 % | $6,208,804 | $6,333,865 | $125,061 | 2.01 % | $0 | | | | | | News Article | History of Wells Fargo Master Trust - Diversified Stock Portfolio Ownership Of Glaxosmithkline Plc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Chickasaw Capital Management Llc | Institution | 7,100 | Sold Some | -49 | -0.68 % | $292,236 | $294,863 | $2,627 | 0.89 % | $-18 | | | | | | News Article | History of Chickasaw Capital Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Connable Office Inc | Institution | 16,833 | No Change | 0 | 0 % | $692,846 | $699,074 | $6,228 | 0.89 % | $0 | | | | | | News Article | History of Connable Office Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Davidson Trust Co | Institution | 7,171 | Sold Some | -300 | -4.01 % | $295,158 | $297,812 | $2,653 | 0.89 % | $-111 | | | | | | News Article | History of Davidson Trust Co Ownership Of Glaxosmithkline Plc |
| 2009-10-30 | 2009-09-30 | N-Q | Forum Funds - Auxier Focus Fund | Multi-Cap Value | 22,950 | No Change | 0 | 0 % | $944,622 | $953,114 | $8,492 | 0.89 % | $0 | | | | | | News Article | History of Forum Funds - Auxier Focus Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-30 | 2009-09-30 | N-Q | Forum Funds - Shaker Fund | Specialty & Misc | | Sold All | -54,364 | -100 % | | | | 0.89 % | $-20,115 | | | | | | News Article | History of Forum Funds - Shaker Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Sit Investment Associates Inc | Institution | 27,116 | Sold Some | -50 | -0.18 % | $1,116,095 | $1,126,127 | $10,033 | 0.89 % | $-19 | | | | | | News Article | History of Sit Investment Associates Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Spears Abacus Advisors Llc | Institution | 17,610 | Sold Some | -1,828 | -9.40 % | $724,828 | $731,343 | $6,516 | 0.89 % | $-676 | | | | | | News Article | History of Spears Abacus Advisors Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-30 | 2009-09-30 | 13F-HR/A | Sterneck Capital Management Llc | No Data | 6,825 | Sold Some | -100 | -1.44 % | $280,917 | $283,442 | $2,525 | 0.89 % | $-37 | | | | | | News Article | History of Sterneck Capital Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Tocqueville Asset Management Lp | Institution | 5,241 | New Holding | 5,241 | 100 % | $215,720 | $217,659 | $1,939 | 0.89 % | $1,939 | | | | | | News Article | History of Tocqueville Asset Management Lp Ownership Of Glaxosmithkline Plc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Wedge Capital Management L L P | Institution | 1,450,603 | Sold Some | -120,806 | -7.68 % | $59,706,819 | $60,243,543 | $536,723 | 0.89 % | $-44,698 | | | | | | News Article | History of Wedge Capital Management L L P Ownership Of Glaxosmithkline Plc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Wesbanco Bank Inc | Institution | 14,960 | No Change | 0 | 0 % | $615,754 | $621,289 | $5,535 | 0.89 % | $0 | | | | | | News Article | History of Wesbanco Bank Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-30 | 2009-08-31 | N-CSRS | Fidelity Commonwealth Trust Ii - Fidelity International Enhanced Index Fund | Global Flex Port | 479 | No Change | 0 | 0 % | $19,716 | $19,893 | $177 | 0.89 % | $0 | | | | | | News Article | History of Fidelity Commonwealth Trust Ii - Fidelity International Enhanced Index Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-30 | 2009-08-31 | N-Q | Oppenheimer International Growth Fund - Oppenheimer International Growth Fund | International Multi-Cap Growth | | Sold All | -226,259 | -100 % | | | | 0.89 % | $-83,716 | | | | | | News Article | History of Oppenheimer International Growth Fund - Oppenheimer International Growth Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-30 | 2009-08-31 | N-Q | Oppenheimer Quest International Value Fund Inc - Oppenheimer Quest International Value Fund Inc | No Data | | Sold All | -195,306 | -100 % | | | | 0.89 % | $-72,263 | | | | | | News Article | History of Oppenheimer Quest International Value Fund Inc - Oppenheimer Quest International Value Fund Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-30 | 2009-08-31 | N-CSR | Vanguard World Fund - Vanguard International Growth Fund | International Large-Cap Core | 1,410,000 | Added More | 160,000 | 12.80 % | $58,035,600 | $58,557,300 | $521,700 | 0.89 % | $59,200 | | | | | | News Article | History of Vanguard World Fund - Vanguard International Growth Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Auxier Asset Management | Institution | 31,210 | No Change | 0 | 0 % | $1,292,406 | $1,296,151 | $3,745 | 0.28 % | $0 | | | | | | News Article | History of Auxier Asset Management Ownership Of Glaxosmithkline Plc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Burnham Asset Management Corp | Institution | 15,729 | Sold Some | -400 | -2.48 % | $651,338 | $653,225 | $1,887 | 0.28 % | $-48 | | | | | | News Article | History of Burnham Asset Management Corp Ownership Of Glaxosmithkline Plc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 268,853 | Added More | 4,487 | 1.69 % | $11,133,203 | $11,165,465 | $32,262 | 0.28 % | $538 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Greenwich Wealth Management Llc | Institution | 126,600 | No Change | 0 | 0 % | $5,242,506 | $5,257,698 | $15,192 | 0.28 % | $0 | | | | | | News Article | History of Greenwich Wealth Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-29 | 2009-09-30 | 13F-HR | John G Ullman And Associates Inc | Institution | 50,950 | Sold Some | -1,100 | -2.11 % | $2,109,840 | $2,115,954 | $6,114 | 0.28 % | $-132 | | | | | | News Article | History of John G Ullman And Associates Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Lincluden Management Ltd | Institution | 97,945 | Sold Some | -6,890 | -6.57 % | $4,055,902 | $4,067,656 | $11,753 | 0.28 % | $-827 | | | | | | News Article | History of Lincluden Management Ltd Ownership Of Glaxosmithkline Plc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Wealthtrust Axiom Llc | Institution | | Sold All | -6,384 | -100 % | | | | 0.28 % | $-766 | | | | | | News Article | History of Wealthtrust Axiom Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-29 | 2009-08-31 | N-Q | Forum Funds - Shaker Fund | Specialty & Misc | 54,364 | New Holding | 54,364 | 100 % | $2,251,213 | $2,257,737 | $6,524 | 0.28 % | $6,524 | | | | | | News Article | History of Forum Funds - Shaker Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-29 | 2009-08-31 | N-Q | Strategic Funds Inc - Global Stock Fund | Global Flex Port | | Sold All | -18,700 | -100 % | | | | 0.28 % | $-2,244 | | | | | | News Article | History of Strategic Funds Inc - Global Stock Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-29 | 2009-08-31 | N-Q | Strategic Funds Inc - International Stock Fund | Global Flex Port | | Sold All | -39,800 | -100 % | | | | 0.28 % | $-4,776 | | | | | | News Article | History of Strategic Funds Inc - International Stock Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-29 | 2009-08-31 | N-Q | Unified Series Trust - Appleseed Fund | Specialty & Misc | | Sold All | -1,400 | -100 % | | | | 0.28 % | $-168 | | | | | | News Article | History of Unified Series Trust - Appleseed Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-29 | 2009-08-31 | N-Q | Unified Series Trust - Marathon Value Portfolio | Multi-Cap Value | 30,240 | Added More | 20,240 | 202.40 % | $1,252,238 | $1,255,867 | $3,629 | 0.28 % | $2,429 | | | | | | News Article | History of Unified Series Trust - Marathon Value Portfolio Ownership Of Glaxosmithkline Plc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Growth Fund | Multi-Cap Growth | 89,500 | New Holding | 89,500 | 100 % | $3,706,195 | $3,716,935 | $10,740 | 0.28 % | $10,740 | | | | | | News Article | History of Usaa Mutual Funds Trust - Growth Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - International Fund | Global Flex Port | 144,267 | New Holding | 144,267 | 100 % | $5,974,096 | $5,991,409 | $17,312 | 0.28 % | $17,312 | | | | | | News Article | History of Usaa Mutual Funds Trust - International Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - International Fund | Global Flex Port | 399,920 | New Holding | 399,920 | 100 % | $16,560,687 | $16,608,678 | $47,990 | 0.28 % | $47,990 | | | | | | News Article | History of Usaa Mutual Funds Trust - International Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Global Strategy Fund | Global Flex Port | 126,106 | New Holding | 126,106 | 100 % | $5,222,049 | $5,237,182 | $15,133 | 0.28 % | $15,133 | | | | | | News Article | History of Valic Co I - Global Strategy Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - International Equities Fund | International Multi-Cap Core | 353,921 | New Holding | 353,921 | 100 % | $14,655,869 | $14,698,339 | $42,471 | 0.28 % | $42,471 | | | | | | News Article | History of Valic Co I - International Equities Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - International Growth I Fund | International Large-Cap Growth | 121,879 | Sold Some | -10,240 | -7.75 % | $5,047,009 | $5,061,635 | $14,625 | 0.28 % | $-1,229 | | | | | | News Article | History of Valic Co I - International Growth I Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Social Awareness Fund | Mixed-Asset Target Allocation Growth | 108,729 | New Holding | 108,729 | 100 % | $4,502,468 | $4,515,515 | $13,047 | 0.28 % | $13,047 | | | | | | News Article | History of Valic Co I - Social Awareness Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Value Fund | Multi-Cap Value | 643,471 | No Change | 0 | 0 % | $26,646,134 | $26,723,351 | $77,217 | 0.28 % | $0 | | | | | | News Article | History of Valic Co I - Value Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-29 | 2009-06-30 | 13F-HR/A | Huntington National Bank | Institution | 87,600 | Sold Some | -1,094 | -1.23 % | $3,627,516 | $3,638,028 | $10,512 | 0.28 % | $-131 | | | | | | News Article | History of Huntington National Bank Ownership Of Glaxosmithkline Plc |
| 2009-10-28 | 2009-09-30 | 13F-HR | Capital City Trust Co | Institution | 6,415 | No Change | 0 | 0 % | $260,577 | $266,415 | $5,838 | 2.24 % | $0 | | | | | | News Article | History of Capital City Trust Co Ownership Of Glaxosmithkline Plc |
| 2009-10-28 | 2009-09-30 | 13F-HR | Chevy Chase Trust Holdings Inc | No Data | 16,356 | Added More | 625 | 3.97 % | $664,381 | $679,265 | $14,884 | 2.24 % | $569 | | | | | | News Article | History of Chevy Chase Trust Holdings Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-28 | 2009-09-30 | 13F-HR | Community Trust And Investment Co | Institution | 91,275 | Added More | 1,630 | 1.81 % | $3,707,591 | $3,790,651 | $83,060 | 2.24 % | $1,483 | | | | | | News Article | History of Community Trust And Investment Co Ownership Of Glaxosmithkline Plc |
| 2009-10-28 | 2009-09-30 | 13F-HR | Courier Capital Corp | Institution | 5,203 | New Holding | 5,203 | 100 % | $211,346 | $216,081 | $4,735 | 2.24 % | $4,735 | | | | | | News Article | History of Courier Capital Corp Ownership Of Glaxosmithkline Plc |
| 2009-10-28 | 2009-09-30 | 13F-HR | Davenport And Co Llc | Institution | 11,297,826 | New Holding | 11,297,826 | 100 % | $458,917,692 | $469,198,714 | $10,281,022 | 2.24 % | $10,281,022 | | | | | | News Article | History of Davenport And Co Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-28 | 2009-09-30 | 13F-HR | Maple Securities Usa Inc | Institution | 24,771 | New Holding | 24,771 | 100 % | $1,006,198 | $1,028,740 | $22,542 | 2.24 % | $22,542 | | | | | | News Article | History of Maple Securities Usa Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-28 | 2009-09-30 | 13F-HR | Sandy Spring Bank | No Data | 2,381 | Added More | 100 | 4.38 % | $96,716 | $98,883 | $2,167 | 2.24 % | $91 | | | | | | News Article | History of Sandy Spring Bank Ownership Of Glaxosmithkline Plc |
| 2009-10-28 | 2009-09-30 | 13F-HR | Schaper Benz And Wise Investment Counsel Inc | Institution | 6,006 | Sold Some | -300 | -4.75 % | $243,964 | $249,429 | $5,465 | 2.24 % | $-273 | | | | | | News Article | History of Schaper Benz And Wise Investment Counsel Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-28 | 2009-09-30 | 13F-HR | Solaris Asset Management Llc | Institution | | Sold All | -5,007 | -100 % | | | | 2.24 % | $-4,556 | | | | | | News Article | History of Solaris Asset Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-28 | 2009-08-31 | N-Q | Alliancebernstein Trust - Alliancebernstein Global Value Fund | Multi-Cap Value | 140,000 | No Change | 0 | 0 % | $5,686,800 | $5,814,200 | $127,400 | 2.24 % | $0 | | | | | | News Article | History of Alliancebernstein Trust - Alliancebernstein Global Value Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-28 | 2009-08-31 | N-Q | Alliancebernstein Trust - Alliancebernstein International Value Fund | Multi-Cap Value | 5,192,400 | Sold Some | -720,000 | -12.17 % | $210,915,288 | $215,640,372 | $4,725,084 | 2.24 % | $-655,200 | | | | | | News Article | History of Alliancebernstein Trust - Alliancebernstein International Value Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-28 | 2009-08-31 | N-Q | Alliancebernstein Trust - Alliancebernstein Value Fund | Multi-Cap Value | 39,800 | No Change | 0 | 0 % | $1,616,676 | $1,652,894 | $36,218 | 2.24 % | $0 | | | | | | News Article | History of Alliancebernstein Trust - Alliancebernstein Value Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-28 | 2009-08-31 | N-Q | American Century Strategic Asset Allocations Inc - Newton Fund | Small-Cap Core | 120,120 | Sold Some | -85,570 | -41.60 % | $4,879,274 | $4,988,584 | $109,309 | 2.24 % | $-77,869 | | | | | | News Article | History of American Century Strategic Asset Allocations Inc - Newton Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-28 | 2009-08-31 | N-Q | American Century World Mutual Funds Inc - International Growth Fund | International Large-Cap Growth | 500,714 | Sold Some | -408,710 | -44.94 % | $20,339,003 | $20,794,652 | $455,650 | 2.24 % | $-371,926 | | | | | | News Article | History of American Century World Mutual Funds Inc - International Growth Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-28 | 2009-08-31 | N-Q | American Century World Mutual Funds Inc - International Stock Fund | International Multi-Cap Value | 24,042 | Sold Some | -19,440 | -44.70 % | $976,586 | $998,464 | $21,878 | 2.24 % | $-17,690 | | | | | | News Article | History of American Century World Mutual Funds Inc - International Stock Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-28 | 2009-08-31 | N-Q | American Century World Mutual Funds Inc - International Value Fund | International Multi-Cap Core | 18,590 | Sold Some | -27,250 | -59.44 % | $755,126 | $772,043 | $16,917 | 2.24 % | $-24,798 | | | | | | News Article | History of American Century World Mutual Funds Inc - International Value Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-28 | 2009-08-31 | N-CSRS | Fidelity Concord Street Trust - Spartan International Index Fund | Global Flex Port | 3,486,698 | Added More | 184,893 | 5.59 % | $141,629,673 | $144,802,568 | $3,172,895 | 2.24 % | $168,253 | | | | | | News Article | History of Fidelity Concord Street Trust - Spartan International Index Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-27 | 2009-09-30 | 13F-HR | First Manhattan Co | Institution | 1,146,562 | Sold Some | -5,724 | -0.49 % | $46,859,989 | $47,616,720 | $756,731 | 1.61 % | $-3,778 | | | | | | News Article | History of First Manhattan Co Ownership Of Glaxosmithkline Plc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Forward Management Llc | Institution | 29,949 | Added More | 8,440 | 39.23 % | $1,224,016 | $1,243,782 | $19,766 | 1.61 % | $5,570 | | | | | | News Article | History of Forward Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Hartford Financial Management Inc | Institution | 45 | No Change | 0 | 0 % | $1,839 | $1,869 | $30 | 1.61 % | $0 | | | | | | News Article | History of Hartford Financial Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Hl Financial Services Llc | Institution | 40,681 | Added More | 475 | 1.18 % | $1,662,632 | $1,689,482 | $26,849 | 1.61 % | $314 | | | | | | News Article | History of Hl Financial Services Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Northwest Investment Counselors Llc | Institution | 8,626 | No Change | 0 | 0 % | $352,545 | $358,238 | $5,693 | 1.61 % | $0 | | | | | | News Article | History of Northwest Investment Counselors Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Seaward Management Corp | Institution | 18,989 | Sold Some | -365 | -1.88 % | $776,080 | $788,613 | $12,533 | 1.61 % | $-241 | | | | | | News Article | History of Seaward Management Corp Ownership Of Glaxosmithkline Plc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Sigma Investment Counselors Inc | Institution | 5,100 | New Holding | 5,100 | 100 % | $208,437 | $211,803 | $3,366 | 1.61 % | $3,366 | | | | | | News Article | History of Sigma Investment Counselors Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Tower Bridge Advisors | Institution | 73,468 | Sold Some | -600 | -0.81 % | $3,002,637 | $3,051,126 | $48,489 | 1.61 % | $-396 | | | | | | News Article | History of Tower Bridge Advisors Ownership Of Glaxosmithkline Plc |
| 2009-10-27 | 2009-09-09 | 13F-HR | First National Bank Of Mount Dora Trust Investment Services | Institution | 61,096 | Added More | 3,201 | 5.52 % | $2,496,994 | $2,537,317 | $40,323 | 1.61 % | $2,113 | | | | | | News Article | History of First National Bank Of Mount Dora Trust Investment Services Ownership Of Glaxosmithkline Plc |
| 2009-10-27 | 2009-08-31 | N-Q | Bragg Capital Trust - Queens Road Value Fund | Multi-Cap Value | | Sold All | -6,000 | -100 % | | | | 1.61 % | $-3,960 | | | | | | News Article | History of Bragg Capital Trust - Queens Road Value Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-26 | 2009-09-30 | 13F-HR | Eveans Bash Magrino And Klein Inc | Institution | 42,793 | Added More | 265 | 0.62 % | $1,724,986 | $1,777,193 | $52,207 | 3.02 % | $323 | | | | | | News Article | History of Eveans Bash Magrino And Klein Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-26 | 2009-09-30 | 13F-HR | Howe And Rusling Inc | Institution | 15,344 | Sold Some | -1,135 | -6.88 % | $618,517 | $637,236 | $18,720 | 3.02 % | $-1,385 | | | | | | News Article | History of Howe And Rusling Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-26 | 2009-09-30 | 13F-HR | Ray Gerald L And Associates Ltd | Institution | 6,547 | No Change | 0 | 0 % | $263,910 | $271,897 | $7,987 | 3.02 % | $0 | | | | | | News Article | History of Ray Gerald L And Associates Ltd Ownership Of Glaxosmithkline Plc |
| 2009-10-26 | 2009-09-30 | 13F-HR | Ray Gerald L And Associates Ltd | Institution | 6,547 | Added More | 47 | 0.72 % | $263,910 | $271,897 | $7,987 | 3.02 % | $57 | | | | | | News Article | History of Ray Gerald L And Associates Ltd Ownership Of Glaxosmithkline Plc |
| 2009-10-26 | 2009-09-30 | 13F-HR/A | Shelter Ins Retirement Plan | No Data | 50,000 | No Change | 0 | 0 % | $2,015,500 | $2,076,500 | $61,000 | 3.02 % | $0 | | | | | | News Article | History of Shelter Ins Retirement Plan Ownership Of Glaxosmithkline Plc |
| 2009-10-26 | 2009-09-30 | 13F-HR | Smith Asset Management Group Lp | Institution | 80 | No Change | 0 | 0 % | $3,225 | $3,322 | $98 | 3.02 % | $0 | | | | | | News Article | History of Smith Asset Management Group Lp Ownership Of Glaxosmithkline Plc |
| 2009-10-26 | 2009-08-31 | N-Q | Claymore Exchange-Traded Fund Trust 2 - Claymorezacks Country Rotation Etf | Specialty & Misc | 1,694 | Sold Some | -194 | -10.27 % | $68,285 | $70,352 | $2,067 | 3.02 % | $-237 | | | | | | News Article | History of Claymore Exchange-Traded Fund Trust 2 - Claymorezacks Country Rotation Etf Ownership Of Glaxosmithkline Plc |
| 2009-10-26 | 2009-08-31 | N-Q | Federated Equity Funds - Federated International Strategic Value Fund | No Data | 5,943 | Added More | 4,615 | 347.51 % | $239,562 | $246,813 | $7,250 | 3.02 % | $5,630 | | | | | | News Article | History of Federated Equity Funds - Federated International Strategic Value Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-26 | 2009-08-31 | N-Q | Federated World Investment Series Inc - Federated International Value Fund | International Multi-Cap Core | | Sold All | -35,705 | -100 % | | | | 3.02 % | $-43,560 | | | | | | News Article | History of Federated World Investment Series Inc - Federated International Value Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-26 | 2009-08-31 | N-Q | Tdax Funds Inc - Tdax Independence 2010 Exchange-Traded Fund | Mixed-Asset Target 2010 Funds | | Sold All | -923 | -100 % | | | | 3.02 % | $-1,126 | | | | | | News Article | History of Tdax Funds Inc - Tdax Independence 2010 Exchange-Traded Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-26 | 2009-08-31 | N-Q | Tdax Funds Inc - Tdax Independence 2020 Exchange-Traded Fund | Mixed-Asset Target 2020 Funds | | Sold All | -5,395 | -100 % | | | | 3.02 % | $-6,582 | | | | | | News Article | History of Tdax Funds Inc - Tdax Independence 2020 Exchange-Traded Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-26 | 2009-08-31 | N-Q | Tdax Funds Inc - Tdax Independence 2030 Exchange-Traded Fund | Mixed-Asset Target 2030 Funds | | Sold All | -6,263 | -100 % | | | | 3.02 % | $-7,641 | | | | | | News Article | History of Tdax Funds Inc - Tdax Independence 2030 Exchange-Traded Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-26 | 2009-08-31 | N-Q | Tdax Funds Inc - Tdax Independence 2040 Exchange-Traded Fund | Mixed-Asset Target 2030+ Funds | | Sold All | -7,030 | -100 % | | | | 3.02 % | $-8,577 | | | | | | News Article | History of Tdax Funds Inc - Tdax Independence 2040 Exchange-Traded Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-26 | 2009-08-31 | N-Q | Tdax Funds Inc - Tdax Independence In-Target Exchange-Traded Fund | Specialty & Misc | | Sold All | -665 | -100 % | | | | 3.02 % | $-811 | | | | | | News Article | History of Tdax Funds Inc - Tdax Independence In-Target Exchange-Traded Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-26 | 2009-06-30 | 13F-HR/A | Ameriprise Financial Inc | Institution | 22,636 | Added More | 5,081 | 28.94 % | $912,457 | $940,073 | $27,616 | 3.02 % | $6,199 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-26 | 2008-09-30 | 13F-HR/A | State Farm Mutual Automobile Insurance Co | Institution | 2,276,000 | No Change | 0 | 0 % | $91,745,560 | $94,522,280 | $2,776,720 | 3.02 % | $0 | | | | | | News Article | History of State Farm Mutual Automobile Insurance Co Ownership Of Glaxosmithkline Plc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Cambridge Investment Research Advisors Inc | Institution | 11,245 | Added More | 1,689 | 17.67 % | $452,499 | $467,005 | $14,506 | 3.20 % | $2,179 | | | | | | News Article | History of Cambridge Investment Research Advisors Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Commerce Bank N A | Institution | 47,807 | Added More | 5,886 | 14.04 % | $1,923,754 | $1,985,425 | $61,671 | 3.20 % | $7,593 | | | | | | News Article | History of Commerce Bank N A Ownership Of Glaxosmithkline Plc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Gateway Investment Advisers Lp | Institution | 349,082 | Sold Some | -114,889 | -24.76 % | $14,047,060 | $14,497,375 | $450,316 | 3.20 % | $-148,207 | | | | | | News Article | History of Gateway Investment Advisers Lp Ownership Of Glaxosmithkline Plc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Haberer Registered Investment Advisor Inc | Institution | 2,301 | Sold Some | -190 | -7.62 % | $92,592 | $95,561 | $2,968 | 3.20 % | $-245 | | | | | | News Article | History of Haberer Registered Investment Advisor Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Killen Group Inc | Institution | 236,984 | Added More | 19,710 | 9.07 % | $9,536,236 | $9,841,946 | $305,709 | 3.20 % | $25,426 | | | | | | News Article | History of Killen Group Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Pinnacle Associates Ltd | Institution | 28,180 | Sold Some | -3,217 | -10.24 % | $1,133,963 | $1,170,315 | $36,352 | 3.20 % | $-4,150 | | | | | | News Article | History of Pinnacle Associates Ltd Ownership Of Glaxosmithkline Plc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Rbc Bank Usa Trust Department | No Data | 1,910 | No Change | 0 | 0 % | $76,858 | $79,322 | $2,464 | 3.20 % | $0 | | | | | | News Article | History of Rbc Bank Usa Trust Department Ownership Of Glaxosmithkline Plc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Susquehanna Trust And Investment Co | Institution | 81,750 | Added More | 3,300 | 4.20 % | $3,289,620 | $3,395,078 | $105,458 | 3.20 % | $4,257 | | | | | | News Article | History of Susquehanna Trust And Investment Co Ownership Of Glaxosmithkline Plc |
| 2009-10-23 | 2009-09-30 | 13F-HR | United Bank Inc | Institution | 5,860 | Sold Some | -2,956 | -33.52 % | $235,806 | $243,366 | $7,559 | 3.20 % | $-3,813 | | | | | | News Article | History of United Bank Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-23 | 2009-08-31 | N-Q | Mfs Series Trust X - Mfs International Value Fund | Multi-Cap Value | 2,142,070 | Added More | 1,444,840 | 207.22 % | $86,196,897 | $88,960,167 | $2,763,270 | 3.20 % | $1,863,844 | | | | | | News Article | History of Mfs Series Trust X - Mfs International Value Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Baker Ellis Asset Management Llc | Institution | 4,552 | New Holding | 4,552 | 100 % | $189,090 | $189,045 | $-46 | -0.02 % | $-46 | | | | | | News Article | History of Baker Ellis Asset Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Bancwest Corp | Institution | 5,758 | New Holding | 5,758 | 100 % | $239,187 | $239,130 | $-58 | -0.02 % | $-58 | | | | | | News Article | History of Bancwest Corp Ownership Of Glaxosmithkline Plc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 233,959 | Sold Some | -4,811 | -2.01 % | $9,718,657 | $9,716,317 | $-2,340 | -0.02 % | $48 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Farmers And Merchants Investments Inc | Institution | 3,860 | New Holding | 3,860 | 100 % | $160,344 | $160,306 | $-39 | -0.02 % | $-39 | | | | | | News Article | History of Farmers And Merchants Investments Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Fcm Investments | Institution | 10,320 | No Change | 0 | 0 % | $428,693 | $428,590 | $-103 | -0.02 % | $0 | | | | | | News Article | History of Fcm Investments Ownership Of Glaxosmithkline Plc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Gannett Welsh And Kotler | Institution | 13,587 | Added More | 1,945 | 16.70 % | $564,404 | $564,268 | $-136 | -0.02 % | $-19 | | | | | | News Article | History of Gannett Welsh And Kotler Ownership Of Glaxosmithkline Plc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Ls Investment Advisors Llc | No Data | 13,028 | Sold Some | -1,462 | -10.08 % | $541,183 | $541,053 | $-130 | -0.02 % | $15 | | | | | | News Article | History of Ls Investment Advisors Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Regions Financial Corp | Institution | 76,139 | Added More | 2,380 | 3.22 % | $3,162,814 | $3,162,053 | $-761 | -0.02 % | $-24 | | | | | | News Article | History of Regions Financial Corp Ownership Of Glaxosmithkline Plc |
| 2009-10-22 | 2009-09-30 | 13F-HR | S And T Bank | Institution | 1,450 | No Change | 0 | 0 % | $60,233 | $60,219 | $-15 | -0.02 % | $0 | | | | | | News Article | History of S And T Bank Ownership Of Glaxosmithkline Plc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Sol Capital Management Co | Institution | 11,654 | Sold Some | -400 | -3.31 % | $484,107 | $483,991 | $-117 | -0.02 % | $4 | | | | | | News Article | History of Sol Capital Management Co Ownership Of Glaxosmithkline Plc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 7,754,729 | Sold Some | -61,977 | -0.79 % | $322,519,179 | $322,053,895 | $-465,284 | -0.14 % | $3,719 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Glaxosmithkline Plc |
| 2009-10-21 | 2009-09-30 | 13F-HR/A | Beck Mack And Oliver Llc | Institution | 53,990 | New Holding | 53,990 | 100 % | $2,245,444 | $2,242,205 | $-3,239 | -0.14 % | $-3,239 | | | | | | News Article | History of Beck Mack And Oliver Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-21 | 2009-09-30 | 13F-HR/A | Beck Mack And Oliver Llc | Institution | 54,330 | New Holding | 54,330 | 100 % | $2,259,585 | $2,256,325 | $-3,260 | -0.14 % | $-3,260 | | | | | | News Article | History of Beck Mack And Oliver Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Boston Advisors Llc | Institution | 67,506 | Added More | 16,320 | 31.88 % | $2,807,575 | $2,803,524 | $-4,050 | -0.14 % | $-979 | | | | | | News Article | History of Boston Advisors Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-21 | 2009-09-30 | 13F-HR | First Midwest Bank Trust Division | Institution | 6,675 | Added More | 93 | 1.41 % | $277,613 | $277,213 | $-401 | -0.14 % | $-6 | | | | | | News Article | History of First Midwest Bank Trust Division Ownership Of Glaxosmithkline Plc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Firstmerit Bank N A Trustee | Institution | 11,996 | Sold Some | -659 | -5.20 % | $498,914 | $498,194 | $-720 | -0.14 % | $40 | | | | | | News Article | History of Firstmerit Bank N A Trustee Ownership Of Glaxosmithkline Plc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Fisher Asset Management Llc | Institution | 5,187,782 | Sold Some | -43,722 | -0.83 % | $215,759,853 | $215,448,586 | $-311,267 | -0.14 % | $2,623 | | | | | | News Article | History of Fisher Asset Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Iwamoto Kong And Co Inc | Institution | 68,760 | Added More | 2,475 | 3.73 % | $2,859,728 | $2,855,603 | $-4,126 | -0.14 % | $-149 | | | | | | News Article | History of Iwamoto Kong And Co Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Navellier And Associates Inc | Institution | 22,336 | Added More | 1,280 | 6.07 % | $928,954 | $927,614 | $-1,340 | -0.14 % | $-77 | | | | | | News Article | History of Navellier And Associates Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Pittenger And Anderson Inc | Institution | 7,500 | No Change | 0 | 0 % | $311,925 | $311,475 | $-450 | -0.14 % | $0 | | | | | | News Article | History of Pittenger And Anderson Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Security National Trust Co | Institution | 3,650 | Sold Some | -2,100 | -36.52 % | $151,804 | $151,585 | $-219 | -0.14 % | $126 | | | | | | News Article | History of Security National Trust Co Ownership Of Glaxosmithkline Plc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Stifel Nicolaus And Co Inc Mo | Institution | 13,954 | Sold Some | -8,359 | -37.46 % | $580,347 | $579,510 | $-837 | -0.14 % | $502 | | | | | | News Article | History of Stifel Nicolaus And Co Inc Mo Ownership Of Glaxosmithkline Plc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Town And Country Bank And Trust Co Dba First Bankers Trust Co | Institution | 11,130 | Added More | 100 | 0.90 % | $462,897 | $462,229 | $-668 | -0.14 % | $-6 | | | | | | News Article | History of Town And Country Bank And Trust Co Dba First Bankers Trust Co Ownership Of Glaxosmithkline Plc |
| 2009-10-20 | 2009-09-30 | 13F-HR | 1st Global Advisors Inc | Institution | 8,160 | Sold Some | -1,518 | -15.68 % | $339,456 | $338,885 | $-571 | -0.16 % | $106 | | | | | | News Article | History of 1st Global Advisors Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Bar Harbor Trust Services | Institution | 7,548 | No Change | 0 | 0 % | $313,997 | $313,468 | $-528 | -0.16 % | $0 | | | | | | News Article | History of Bar Harbor Trust Services Ownership Of Glaxosmithkline Plc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Griffin Asset Management Inc | Institution | 6,400 | No Change | 0 | 0 % | $266,240 | $265,792 | $-448 | -0.16 % | $0 | | | | | | News Article | History of Griffin Asset Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Kanawha Capital Management Llc | Institution | 28,204 | Added More | 1,900 | 7.22 % | $1,173,286 | $1,171,312 | $-1,974 | -0.16 % | $-133 | | | | | | News Article | History of Kanawha Capital Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Leeb Capital Management Inc | Institution | 9,500 | Sold Some | -1,125 | -10.58 % | $395,200 | $394,535 | $-665 | -0.16 % | $79 | | | | | | News Article | History of Leeb Capital Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Mackay Shields Llc | Institution | 311,550 | Sold Some | -91,250 | -22.65 % | $12,960,480 | $12,938,672 | $-21,809 | -0.16 % | $6,388 | | | | | | News Article | History of Mackay Shields Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Shelter Ins Profit Sharing | No Data | 48,000 | No Change | 0 | 0 % | $1,996,800 | $1,993,440 | $-3,360 | -0.16 % | $0 | | | | | | News Article | History of Shelter Ins Profit Sharing Ownership Of Glaxosmithkline Plc |
| 2009-10-19 | 2009-09-30 | 13F-HR | City National Bank | Institution | 13,025 | Sold Some | -582 | -4.27 % | $545,878 | $540,928 | $-4,950 | -0.90 % | $221 | | | | | | News Article | History of City National Bank Ownership Of Glaxosmithkline Plc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Confluence Investment Management Llc | Institution | 78,373 | Added More | 12,607 | 19.16 % | $3,284,612 | $3,254,831 | $-29,782 | -0.90 % | $-4,791 | | | | | | News Article | History of Confluence Investment Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Guyasuta Investment Advisors Inc | Institution | 5,577 | New Holding | 5,577 | 100 % | $233,732 | $231,613 | $-2,119 | -0.90 % | $-2,119 | | | | | | News Article | History of Guyasuta Investment Advisors Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Rothschild Investment Corp | Institution | 35,599 | Sold Some | -126 | -0.35 % | $1,491,954 | $1,478,426 | $-13,528 | -0.90 % | $48 | | | | | | News Article | History of Rothschild Investment Corp Ownership Of Glaxosmithkline Plc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Strs Ohio | Institution | 418,461 | No Change | 0 | 0 % | $17,537,701 | $17,378,685 | $-159,015 | -0.90 % | $0 | | | | | | News Article | History of Strs Ohio Ownership Of Glaxosmithkline Plc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Tompkins Trustco Inc | Institution | 112 | No Change | 0 | 0 % | $4,694 | $4,651 | $-43 | -0.90 % | $0 | | | | | | News Article | History of Tompkins Trustco Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Trust Co Of Virginia | Institution | 123,588 | Added More | 2,768 | 2.29 % | $5,179,573 | $5,132,610 | $-46,963 | -0.90 % | $-1,052 | | | | | | News Article | History of Trust Co Of Virginia Ownership Of Glaxosmithkline Plc |
| 2009-10-16 | 2009-09-30 | 13F-HR | Amg National Trust Bank | Institution | 33,341 | Sold Some | -1,681 | -4.79 % | $1,373,649 | $1,384,652 | $11,003 | 0.80 % | $-555 | | | | | | News Article | History of Amg National Trust Bank Ownership Of Glaxosmithkline Plc |
| 2009-10-16 | 2009-09-30 | 13F-HR | Capstone Asset Management Co | Institution | 105,900 | Added More | 245 | 0.23 % | $4,363,080 | $4,398,027 | $34,947 | 0.80 % | $81 | | | | | | News Article | History of Capstone Asset Management Co Ownership Of Glaxosmithkline Plc |
| 2009-10-16 | 2009-09-30 | 13F-HR | Charter Trust Co | Institution | 93,277 | Sold Some | -100 | -0.10 % | $3,843,012 | $3,873,794 | $30,781 | 0.80 % | $-33 | | | | | | News Article | History of Charter Trust Co Ownership Of Glaxosmithkline Plc |
| 2009-10-16 | 2009-09-30 | 13F-HR | First Horizon National Corp | Institution | 32,737 | No Change | 0 | 0 % | $1,348,764 | $1,359,568 | $10,803 | 0.80 % | $0 | | | | | | News Article | History of First Horizon National Corp Ownership Of Glaxosmithkline Plc |
| 2009-10-16 | 2009-09-30 | 13F-HR | Garland Capital Management Inc | Institution | 65,140 | Added More | 400 | 0.61 % | $2,683,768 | $2,705,264 | $21,496 | 0.80 % | $132 | | | | | | News Article | History of Garland Capital Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-16 | 2009-09-30 | 13F-HR | Manning And Napier Advisors Inc | Institution | 206,733 | Added More | 110,821 | 115.54 % | $8,517,400 | $8,585,621 | $68,222 | 0.80 % | $36,571 | | | | | | News Article | History of Manning And Napier Advisors Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-16 | 2009-09-30 | 13F-HR | Trust Co Of Vermont | Institution | 2,406 | Added More | 87 | 3.75 % | $99,127 | $99,921 | $794 | 0.80 % | $29 | | | | | | News Article | History of Trust Co Of Vermont Ownership Of Glaxosmithkline Plc |
| 2009-10-16 | 2009-09-30 | 13F-HR | Welch And Forbes Llc | Institution | 467,047 | Sold Some | -2,475 | -0.52 % | $19,242,336 | $19,396,462 | $154,126 | 0.80 % | $-817 | | | | | | News Article | History of Welch And Forbes Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-16 | 2009-09-30 | 13F-HR | Wright Investors Service Inc | Institution | 22,780 | Sold Some | -1,497 | -6.16 % | $938,536 | $946,053 | $7,517 | 0.80 % | $-494 | | | | | | News Article | History of Wright Investors Service Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Butler Wick Trust Co | Institution | 8,437 | No Change | 0 | 0 % | $348,279 | $350,389 | $2,109 | 0.60 % | $0 | | | | | | News Article | History of Butler Wick Trust Co Ownership Of Glaxosmithkline Plc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Harris Financial Corp | Institution | 622,912 | Sold Some | -36,692 | -5.56 % | $25,713,807 | $25,869,535 | $155,728 | 0.60 % | $-9,173 | | | | | | News Article | History of Harris Financial Corp Ownership Of Glaxosmithkline Plc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Public Employees Retirement System Of Ohio | Institution | 2,000 | No Change | 0 | 0 % | $82,560 | $83,060 | $500 | 0.60 % | $0 | | | | | | News Article | History of Public Employees Retirement System Of Ohio Ownership Of Glaxosmithkline Plc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Raymond James Financial Services Advisors Inc | No Data | 17,308 | Added More | 3,582 | 26.09 % | $714,474 | $718,801 | $4,327 | 0.60 % | $896 | | | | | | News Article | History of Raymond James Financial Services Advisors Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Salem Capital Management Inc | Institution | 117,400 | Added More | 400 | 0.34 % | $4,846,272 | $4,875,622 | $29,350 | 0.60 % | $100 | | | | | | News Article | History of Salem Capital Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Scott And Stringfellow Financial Inc | Institution | 21,204 | Added More | 9,712 | 84.51 % | $875,301 | $880,602 | $5,301 | 0.60 % | $2,428 | | | | | | News Article | History of Scott And Stringfellow Financial Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-15 | 2007-03-31 | 13F-HR/A | Northwestern Mutual Life Insurance Co | Institution | | Sold All | -12,202 | -100 % | | | | 0.60 % | $-3,051 | | | | | | News Article | History of Northwestern Mutual Life Insurance Co Ownership Of Glaxosmithkline Plc |
| 2009-10-14 | 2009-09-30 | 13F-HR/A | Adirondack Trust Co | Institution | 400 | No Change | 0 | 0 % | $16,128 | $16,612 | $484 | 3.00 % | $0 | | | | | | News Article | History of Adirondack Trust Co Ownership Of Glaxosmithkline Plc |
| 2009-10-14 | 2009-09-30 | 13F-HR | Arrow Financial Corp | Institution | 990 | Added More | 265 | 36.55 % | $39,917 | $41,115 | $1,198 | 3.00 % | $321 | | | | | | News Article | History of Arrow Financial Corp Ownership Of Glaxosmithkline Plc |
| 2009-10-14 | 2009-09-30 | 13F-HR | Balasa Dinverno And Foltz Llc | Institution | 12,106 | Sold Some | -221 | -1.79 % | $488,114 | $502,762 | $14,648 | 3.00 % | $-267 | | | | | | News Article | History of Balasa Dinverno And Foltz Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-14 | 2009-09-30 | 13F-HR | First National Bank Sioux Falls | Institution | 450 | No Change | 0 | 0 % | $18,144 | $18,689 | $545 | 3.00 % | $0 | | | | | | News Article | History of First National Bank Sioux Falls Ownership Of Glaxosmithkline Plc |
| 2009-10-14 | 2009-09-30 | 13F-HR | Georgia Bennicas Dba Bennicas And Associates | Institution | 53,150 | Sold Some | -3,100 | -5.51 % | $2,143,008 | $2,207,320 | $64,312 | 3.00 % | $-3,751 | | | | | | News Article | History of Georgia Bennicas Dba Bennicas And Associates Ownership Of Glaxosmithkline Plc |
| 2009-10-14 | 2009-09-30 | 13F-HR | Independent Portfolio Consultants Inc | No Data | 19,596 | Added More | 1,619 | 9.00 % | $790,111 | $813,822 | $23,711 | 3.00 % | $1,959 | | | | | | News Article | History of Independent Portfolio Consultants Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-14 | 2009-09-30 | 13F-HR | Intrust Bank Na | Institution | 21,479 | Added More | 348 | 1.64 % | $866,033 | $892,023 | $25,990 | 3.00 % | $421 | | | | | | News Article | History of Intrust Bank Na Ownership Of Glaxosmithkline Plc |
| 2009-10-14 | 2009-09-30 | 13F-HR | Murphy Capital Management Inc | Institution | 9,945 | Sold Some | -447 | -4.30 % | $400,982 | $413,016 | $12,033 | 3.00 % | $-541 | | | | | | News Article | History of Murphy Capital Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-13 | 2009-09-30 | 13F-HR | Adams Asset Advisors Llc | Institution | 85,145 | Sold Some | -19,305 | -18.48 % | $3,379,405 | $3,536,072 | $156,667 | 4.63 % | $-35,521 | | | | | | News Article | History of Adams Asset Advisors Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-13 | 2009-09-30 | 13F-HR | Associated Banc Corp | Institution | 8,540 | Sold Some | -2,246 | -20.82 % | $338,953 | $354,666 | $15,714 | 4.63 % | $-4,133 | | | | | | News Article | History of Associated Banc Corp Ownership Of Glaxosmithkline Plc |
| 2009-10-13 | 2009-09-30 | 13F-HR | Blb And B Advisors Llc | Institution | 16,309 | Added More | 1,550 | 10.50 % | $647,304 | $677,313 | $30,009 | 4.63 % | $2,852 | | | | | | News Article | History of Blb And B Advisors Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-13 | 2009-09-30 | 13F-HR | Financial Architects Inc | Institution | 3,784 | Sold Some | -15 | -0.39 % | $150,187 | $157,150 | $6,963 | 4.63 % | $-28 | | | | | | News Article | History of Financial Architects Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-13 | 2009-09-30 | 13F-HR | Gofen And Glossberg Llc | Institution | 24,649 | Sold Some | -513 | -2.03 % | $978,319 | $1,023,673 | $45,354 | 4.63 % | $-944 | | | | | | News Article | History of Gofen And Glossberg Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-13 | 2009-09-30 | 13F-HR | Lowe Brockenbrough And Co Inc | Institution | 17,524 | Sold Some | -100 | -0.56 % | $695,528 | $727,772 | $32,244 | 4.63 % | $-184 | | | | | | News Article | History of Lowe Brockenbrough And Co Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-13 | 2009-09-30 | 13F-HR | Stockman Asset Management | Institution | 47,876 | Sold Some | -5,637 | -10.53 % | $1,900,198 | $1,988,290 | $88,092 | 4.63 % | $-10,372 | | | | | | News Article | History of Stockman Asset Management Ownership Of Glaxosmithkline Plc |
| 2009-10-13 | 2009-09-30 | 13F-HR | Thomaspartners Inc | Institution | 16,083 | Added More | 2,399 | 17.53 % | $638,334 | $667,927 | $29,593 | 4.63 % | $4,414 | | | | | | News Article | History of Thomaspartners Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-09 | 2009-09-30 | 13F-HR | Gries Financial Llc | Institution | | Sold All | -8,481 | -100 % | | | | 4.68 % | $-15,775 | | | | | | News Article | History of Gries Financial Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-09 | 2009-09-30 | 13F-HR | Mitchell Sinkler And Starr | Institution | 27,029 | No Change | 0 | 0 % | $1,072,240 | $1,122,514 | $50,274 | 4.68 % | $0 | | | | | | News Article | History of Mitchell Sinkler And Starr Ownership Of Glaxosmithkline Plc |
| 2009-10-09 | 2009-09-30 | 13F-HR | Pacific Capital Bancorp | Institution | 5,348 | New Holding | 5,348 | 100 % | $212,155 | $222,102 | $9,947 | 4.68 % | $9,947 | | | | | | News Article | History of Pacific Capital Bancorp Ownership Of Glaxosmithkline Plc |
| 2009-10-09 | 2009-09-30 | 13F-HR | Progressive Investment Management | Institution | 1,300 | No Change | 0 | 0 % | $51,571 | $53,989 | $2,418 | 4.68 % | $0 | | | | | | News Article | History of Progressive Investment Management Ownership Of Glaxosmithkline Plc |
| 2009-10-09 | 2009-09-30 | 13F-HR | Stack Financial Management Inc | Institution | 131,453 | Added More | 2,080 | 1.60 % | $5,214,741 | $5,459,243 | $244,503 | 4.68 % | $3,869 | | | | | | News Article | History of Stack Financial Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-09 | 2008-12-31 | 13F-HR/A | State Farm Investment Management Corp | Insider | 2,276,000 | No Compare | | | $90,288,920 | $94,522,280 | $4,233,360 | 4.68 % | | | | | | | News Article | History of State Farm Investment Management Corp Ownership Of Glaxosmithkline Plc |
| 2009-10-09 | 2008-12-31 | 13F-HR/A | State Farm Mutual Automobile Insurance Co | Institution | 2,276,000 | No Change | 0 | 0 % | $90,288,920 | $94,522,280 | $4,233,360 | 4.68 % | $0 | | | | | | News Article | History of State Farm Mutual Automobile Insurance Co Ownership Of Glaxosmithkline Plc |
| 2009-10-08 | 2009-09-30 | 13F-HR/A | First Citizens Bancorporation Inc | Institution | 12,417 | No Change | 0 | 0 % | $491,465 | $515,678 | $24,213 | 4.92 % | $0 | | | | | | News Article | History of First Citizens Bancorporation Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-08 | 2009-09-30 | 13F-HR | West Oak Capital Llc | Institution | 55 | No Change | 0 | 0 % | $2,177 | $2,284 | $107 | 4.92 % | $0 | | | | | | News Article | History of West Oak Capital Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-07 | 2009-09-30 | 13F-HR | Boston Private Bank And Trust Co | Institution | 29,074 | Sold Some | -410 | -1.39 % | $1,143,190 | $1,207,443 | $64,254 | 5.62 % | $-906 | | | | | | News Article | History of Boston Private Bank And Trust Co Ownership Of Glaxosmithkline Plc |
| 2009-10-07 | 2009-09-30 | 13F-HR | Jaffetilchin Investment Partners Llc | Institution | 28,699 | New Holding | 28,699 | 100 % | $1,128,445 | $1,191,869 | $63,425 | 5.62 % | $63,425 | | | | | | News Article | History of Jaffetilchin Investment Partners Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-07 | 2009-09-30 | 13F-HR | National Penn Investors Trust Co | Institution | 31,672 | Sold Some | -1,916 | -5.70 % | $1,245,343 | $1,315,338 | $69,995 | 5.62 % | $-4,234 | | | | | | News Article | History of National Penn Investors Trust Co Ownership Of Glaxosmithkline Plc |
| 2009-10-07 | 2009-09-30 | 13F-HR | Oak Associates Ltd | Institution | 36,800 | No Change | 0 | 0 % | $1,446,976 | $1,528,304 | $81,328 | 5.62 % | $0 | | | | | | News Article | History of Oak Associates Ltd Ownership Of Glaxosmithkline Plc |
| 2009-10-07 | 2009-09-30 | 13F-HR | Terre Haute First National Bank | Institution | 1,165 | No Change | 0 | 0 % | $45,808 | $48,382 | $2,575 | 5.62 % | $0 | | | | | | News Article | History of Terre Haute First National Bank Ownership Of Glaxosmithkline Plc |
| 2009-10-07 | 2009-09-30 | 13F-HR | Tiaa Cref Trust Co Fsb | Institution | 21,001 | Sold Some | -5,339 | -20.26 % | $825,759 | $872,172 | $46,412 | 5.62 % | $-11,799 | | | | | | News Article | History of Tiaa Cref Trust Co Fsb Ownership Of Glaxosmithkline Plc |
| 2009-10-07 | 2009-07-31 | N-CSR | Profunds - Europe 30 Profund | European Region | 10,541 | Added More | 8,133 | 337.74 % | $414,472 | $437,768 | $23,296 | 5.62 % | $17,974 | | | | | | News Article | History of Profunds - Europe 30 Profund Ownership Of Glaxosmithkline Plc |
| 2009-10-07 | 2009-07-31 | N-CSRS | Sunamerica Series Trust - Foreign Value Portfolio | Multi-Cap Value | 435,897 | No Change | 0 | 0 % | $17,139,470 | $18,102,802 | $963,332 | 5.62 % | $0 | | | | | | News Article | History of Sunamerica Series Trust - Foreign Value Portfolio Ownership Of Glaxosmithkline Plc |
| 2009-10-07 | 2009-07-31 | N-CSRS | Sunamerica Series Trust - International Diversified Equities Portfolio | Global Flex Port | 153,077 | Sold Some | -85,622 | -35.87 % | $6,018,988 | $6,357,288 | $338,300 | 5.62 % | $-189,225 | | | | | | News Article | History of Sunamerica Series Trust - International Diversified Equities Portfolio Ownership Of Glaxosmithkline Plc |
| 2009-10-07 | 2009-07-31 | N-CSRS | Sunamerica Series Trust - Mfs Total Return Portfolio | Specialty & Misc | | Sold All | -62,650 | -100 % | | | | 5.62 % | $-138,457 | | | | | | News Article | History of Sunamerica Series Trust - Mfs Total Return Portfolio Ownership Of Glaxosmithkline Plc |
| 2009-10-07 | 2009-07-31 | N-CSR | Unified Series Trust - Appleseed Fund | Specialty & Misc | 1,400 | New Holding | 1,400 | 100 % | $55,048 | $58,142 | $3,094 | 5.62 % | $3,094 | | | | | | News Article | History of Unified Series Trust - Appleseed Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-06 | 2009-09-30 | 13F-HR | Coolidge Francis L | Institution | 1,133 | No Change | 0 | 0 % | $44,482 | $47,053 | $2,572 | 5.78 % | $0 | | | | | | News Article | History of Coolidge Francis L Ownership Of Glaxosmithkline Plc |
| 2009-10-06 | 2009-09-30 | 13F-HR | Franklin Street Advisors Inc | Institution | 54,952 | Sold Some | -1,090 | -1.94 % | $2,157,416 | $2,282,157 | $124,741 | 5.78 % | $-2,474 | | | | | | News Article | History of Franklin Street Advisors Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-06 | 2009-09-30 | 13F-HR | Hall Martin | Institution | 300 | Added More | 100 | 50.00 % | $11,778 | $12,459 | $681 | 5.78 % | $227 | | | | | | News Article | History of Hall Martin Ownership Of Glaxosmithkline Plc |
| 2009-10-06 | 2009-09-30 | 13F-HR | Joyce Edward J | Institution | 3,600 | No Change | 0 | 0 % | $141,336 | $149,508 | $8,172 | 5.78 % | $0 | | | | | | News Article | History of Joyce Edward J Ownership Of Glaxosmithkline Plc |
| 2009-10-06 | 2009-09-30 | 13F-HR | Palladium Partners Llc | No Data | 10,211 | Sold Some | -50 | -0.48 % | $400,884 | $424,063 | $23,179 | 5.78 % | $-114 | | | | | | News Article | History of Palladium Partners Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-06 | 2009-09-30 | 13F-HR | Shapiro Robert N | Institution | 3,268 | No Change | 0 | 0 % | $128,302 | $135,720 | $7,418 | 5.78 % | $0 | | | | | | News Article | History of Shapiro Robert N Ownership Of Glaxosmithkline Plc |
| 2009-10-05 | 2009-09-30 | 13F-HR | Bb And T Corp | Institution | 30,252 | Sold Some | -769 | -2.47 % | $1,175,593 | $1,256,366 | $80,773 | 6.87 % | $-2,053 | | | | | | News Article | History of Bb And T Corp Ownership Of Glaxosmithkline Plc |
| 2009-10-05 | 2009-09-30 | 13F-HR | Natcan Investment Management Inc | Institution | 15,922 | Sold Some | -15,404 | -49.17 % | $618,729 | $661,241 | $42,512 | 6.87 % | $-41,129 | | | | | | News Article | History of Natcan Investment Management Inc Ownership Of Glaxosmithkline Plc |
| 2009-10-05 | 2009-07-31 | N-CSR | Henderson Global Funds - Henderson Global Equity Income Fund | Global Flex Port | 342,289 | New Holding | 342,289 | 100 % | $13,301,351 | $14,215,262 | $913,912 | 6.87 % | $913,912 | | | | | | News Article | History of Henderson Global Funds - Henderson Global Equity Income Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-02 | 2009-09-30 | 13F-HR | First American Trust Co | Institution | 18,138 | Sold Some | -2,162 | -10.65 % | $702,303 | $753,271 | $50,968 | 7.25 % | $-6,075 | | | | | | News Article | History of First American Trust Co Ownership Of Glaxosmithkline Plc |
| 2009-10-02 | 2009-09-30 | 13F-HR | Fulton Financial Advisors N A | Institution | 66,612 | Added More | 6,077 | 10.03 % | $2,579,217 | $2,766,396 | $187,180 | 7.25 % | $17,076 | | | | | | News Article | History of Fulton Financial Advisors N A Ownership Of Glaxosmithkline Plc |
| 2009-10-02 | 2009-09-30 | 13F-HR | Vigilant Capital Management Llc | Institution | 11 | Sold Some | -899 | -98.79 % | $426 | $457 | $31 | 7.25 % | $-2,526 | | | | | | News Article | History of Vigilant Capital Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Growth Fund | Multi-Cap Growth | | Sold All | -89,500 | -100 % | | | | 7.25 % | $-251,495 | | | | | | News Article | History of Usaa Mutual Funds Trust - Growth Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Value Fund | Multi-Cap Value | | Sold All | -23,916 | -100 % | | | | 7.25 % | $-67,204 | | | | | | News Article | History of Usaa Mutual Funds Trust - Value Fund Ownership Of Glaxosmithkline Plc |
| 2009-10-01 | 2009-09-30 | 13F-HR | Inverness Counsel Inc | Institution | 7,080 | No Change | 0 | 0 % | $274,350 | $294,032 | $19,682 | 7.17 % | $0 | | | | | | News Article | History of Inverness Counsel Inc Ownership Of Glaxosmithkline Plc |
| 2009-09-30 | 2009-07-31 | N-CSR | Wells Fargo Funds Trust - Social Sustainability Fund | No Data | 1,072 | Added More | 151 | 16.39 % | $42,355 | $44,520 | $2,165 | 5.11 % | $305 | | | | | | News Article | History of Wells Fargo Funds Trust - Social Sustainability Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-30 | 2009-03-31 | 13F-HR/A | Atherton Lane Advisers Llc | Institution | | Sold All | -5,800 | -100 % | | | | 5.11 % | $-11,716 | | | | | | News Article | History of Atherton Lane Advisers Llc Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Aim International Mutual Funds - Aim International Core Equity Fund | International Large-Cap Core | 367,147 | Added More | 13,715 | 3.88 % | $14,550,036 | $15,247,615 | $697,579 | 4.79 % | $26,059 | | | | | | News Article | History of Aim International Mutual Funds - Aim International Core Equity Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Alger Fund - Alger Convertible Fund | No Data | 13,000 | No Change | 0 | 0 % | $515,190 | $539,890 | $24,700 | 4.79 % | $0 | | | | | | News Article | History of Alger Fund - Alger Convertible Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Axp Global Series Inc - Threadneedle Global Equity Income Fund | No Data | 19,626 | Added More | 3,943 | 25.14 % | $777,778 | $815,068 | $37,289 | 4.79 % | $7,492 | | | | | | News Article | History of Axp Global Series Inc - Threadneedle Global Equity Income Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Delaware Pooled Trust Inc - The International Equity Portfolio | Global Flex Port | 1,601,331 | Sold Some | -46,307 | -2.81 % | $63,460,748 | $66,503,276 | $3,042,529 | 4.79 % | $-87,983 | | | | | | News Article | History of Delaware Pooled Trust Inc - The International Equity Portfolio Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Delaware Pooled Trust Inc - The Labor Select International Equity Portfolio | Global Flex Port | 1,277,328 | Added More | 37,150 | 2.99 % | $50,620,509 | $53,047,432 | $2,426,923 | 4.79 % | $70,585 | | | | | | News Article | History of Delaware Pooled Trust Inc - The Labor Select International Equity Portfolio Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Large Cap International Portfolio | International Large-Cap Core | 503,498 | New Holding | 503,498 | 100 % | $19,953,626 | $20,910,272 | $956,646 | 4.79 % | $956,646 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Large Cap International Portfolio Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Dreyfus Premier International Funds Inc - International Growth Fund | International Large-Cap Core | 27,740 | New Holding | 27,740 | 100 % | $1,099,336 | $1,152,042 | $52,706 | 4.79 % | $52,706 | | | | | | News Article | History of Dreyfus Premier International Funds Inc - International Growth Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Dunham Funds - Dunham International Stock Fund | No Data | 25,853 | Sold Some | -6,259 | -19.49 % | $1,024,554 | $1,073,675 | $49,121 | 4.79 % | $-11,892 | | | | | | News Article | History of Dunham Funds - Dunham International Stock Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Dws Advisor Funds - Dws International Equity Fund | Global Flex Port | 77,118 | New Holding | 77,118 | 100 % | $3,056,186 | $3,202,711 | $146,524 | 4.79 % | $146,524 | | | | | | News Article | History of Dws Advisor Funds - Dws International Equity Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Dws Balanced Fund - Dws Balanced Fund | Flexible Portfolio | 31,372 | Added More | 12,020 | 62.11 % | $1,243,272 | $1,302,879 | $59,607 | 4.79 % | $22,838 | | | | | | News Article | History of Dws Balanced Fund - Dws Balanced Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Dws International Fund Inc - Dws Europe Equity Fund | European Region | 205,660 | Sold Some | -234,064 | -53.22 % | $8,150,306 | $8,541,060 | $390,754 | 4.79 % | $-444,722 | | | | | | News Article | History of Dws International Fund Inc - Dws Europe Equity Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q/A | Eaton Vance Mutual Funds Trust - Eaton Vance Equity Research Fund | Specialty & Misc | 84,700 | New Holding | 84,700 | 100 % | $3,356,661 | $3,517,591 | $160,930 | 4.79 % | $160,930 | | | | | | News Article | History of Eaton Vance Mutual Funds Trust - Eaton Vance Equity Research Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q/A | Eaton Vance Mutual Funds Trust - Eaton Vance International Equity Fund | Global Flex Port | 13,800 | Added More | 7,300 | 112.30 % | $546,894 | $573,114 | $26,220 | 4.79 % | $13,870 | | | | | | News Article | History of Eaton Vance Mutual Funds Trust - Eaton Vance International Equity Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Fidelity Advisor Series Viii - Diversified International Fund | International Multi-Cap Core | | Sold All | -1,383,600 | -100 % | | | | 4.79 % | $-2,628,840 | | | | | | News Article | History of Fidelity Advisor Series Viii - Diversified International Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Fidelity Advisor Series Viii - Japan Fund | Japanese | | Sold All | -643,200 | -100 % | | | | 4.79 % | $-1,222,080 | | | | | | News Article | History of Fidelity Advisor Series Viii - Japan Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Fidelity Advisor Series Viii - Overseas Fund | International Large-Cap Core | 132,800 | Sold Some | -572,800 | -81.17 % | $5,262,864 | $5,515,184 | $252,320 | 4.79 % | $-1,088,320 | | | | | | News Article | History of Fidelity Advisor Series Viii - Overseas Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Fidelity Investment Trust - Fidelity Europe Fund | European Region | 3,539,216 | New Holding | 3,539,216 | 100 % | $140,259,130 | $146,983,640 | $6,724,510 | 4.79 % | $6,724,510 | | | | | | News Article | History of Fidelity Investment Trust - Fidelity Europe Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | First American Investment Funds Inc - International Fund | International Multi-Cap Core | 420,490 | New Holding | 420,490 | 100 % | $16,664,019 | $17,462,950 | $798,931 | 4.79 % | $798,931 | | | | | | News Article | History of First American Investment Funds Inc - International Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | First American Investment Funds Inc - International Select Fund | International Small-Mid-Cap Growth | 207,705 | Added More | 38,615 | 22.83 % | $8,231,349 | $8,625,989 | $394,640 | 4.79 % | $73,369 | | | | | | News Article | History of First American Investment Funds Inc - International Select Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Goldman Sachs Trust - Goldman Sachs Structured International Equity Flex Fund | Gold Oriented | 10,284 | New Holding | 10,284 | 100 % | $407,555 | $427,095 | $19,540 | 4.79 % | $19,540 | | | | | | News Article | History of Goldman Sachs Trust - Goldman Sachs Structured International Equity Flex Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Hartford Mutual Funds Incct - Hartford Advisers Fund | Mixed-Asset Target Allocation Growth | 145 | New Holding | 145 | 100 % | $5,746 | $6,022 | $276 | 4.79 % | $276 | | | | | | News Article | History of Hartford Mutual Funds Incct - Hartford Advisers Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Hartford Mutual Funds Incct - Hartford Balanced Income Fund | Mixed-Asset Target Allocation Moderate | 6 | Sold Some | -1 | -14.28 % | $238 | $249 | $11 | 4.79 % | $-2 | | | | | | News Article | History of Hartford Mutual Funds Incct - Hartford Balanced Income Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Hartford Mutual Funds Incct - Hartford Equity Income Fund | Equity Income | 152 | No Change | 0 | 0 % | $6,024 | $6,313 | $289 | 4.79 % | $0 | | | | | | News Article | History of Hartford Mutual Funds Incct - Hartford Equity Income Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Hartford Mutual Funds Incct - The Hartford Diversified International Fund | No Data | | Sold All | -2 | -100 % | | | | 4.79 % | $-4 | | | | | | News Article | History of Hartford Mutual Funds Incct - The Hartford Diversified International Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Heritage Series Trust - International Equity Fund | Global Flex Port | 78,342 | New Holding | 78,342 | 100 % | $3,104,693 | $3,253,543 | $148,850 | 4.79 % | $148,850 | | | | | | News Article | History of Heritage Series Trust - International Equity Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Hsbc Advisor Funds Trust - Opportunity Fund | Specialty & Misc | 213,800 | No Change | 0 | 0 % | $8,472,894 | $8,879,114 | $406,220 | 4.79 % | $0 | | | | | | News Article | History of Hsbc Advisor Funds Trust - Opportunity Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Hsbc Investor Funds - Hsbc Investor Oppurtunity Fund | Specialty & Misc | 213,800 | Sold Some | -213,800 | -50.00 % | $8,472,894 | $8,879,114 | $406,220 | 4.79 % | $-406,220 | | | | | | News Article | History of Hsbc Investor Funds - Hsbc Investor Oppurtunity Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Hsbc Investor Portfolios - International Equity Portfolio | Global Flex Port | 213,800 | No Change | 0 | 0 % | $8,472,894 | $8,879,114 | $406,220 | 4.79 % | $0 | | | | | | News Article | History of Hsbc Investor Portfolios - International Equity Portfolio Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-CSR | Janus Investment Fund - Intech Risk-Managed International Fund | No Data | 3,565 | No Compare | | | $141,281 | $148,054 | $6,774 | 4.79 % | | | | | | | News Article | History of Janus Investment Fund - Intech Risk-Managed International Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Janus Investment Fund - Janus Fund | Large-Cap Growth | 300,632 | New Holding | 300,632 | 100 % | $11,914,046 | $12,485,247 | $571,201 | 4.79 % | $571,201 | | | | | | News Article | History of Janus Investment Fund - Janus Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Janus Investment Fund - Janus Global Opportunities Fund | Global Multi-Cap Value | 111,694 | New Holding | 111,694 | 100 % | $4,426,433 | $4,638,652 | $212,219 | 4.79 % | $212,219 | | | | | | News Article | History of Janus Investment Fund - Janus Global Opportunities Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Janus Investment Fund - Janus Global Research Fund | Global Flex Port | 114,745 | Sold Some | -707 | -0.61 % | $4,547,344 | $4,765,360 | $218,016 | 4.79 % | $-1,343 | | | | | | News Article | History of Janus Investment Fund - Janus Global Research Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Janus Investment Fund - Janus Research Fund | Global Multi-Cap Growth | 2,044,453 | New Holding | 2,044,453 | 100 % | $81,021,672 | $84,906,133 | $3,884,461 | 4.79 % | $3,884,461 | | | | | | News Article | History of Janus Investment Fund - Janus Research Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Jnl Investors Series Trust - Jackson Perspective Index 5 Fund | Specialty & Misc | 5,232 | Sold Some | -6,070 | -53.70 % | $207,344 | $217,285 | $9,941 | 4.79 % | $-11,533 | | | | | | News Article | History of Jnl Investors Series Trust - Jackson Perspective Index 5 Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Johnsonfamily Funds Inc - Johnsonfamily Large Cap Value Fund | Large-Cap Value | 3,850 | Sold Some | -9,585 | -71.34 % | $152,576 | $159,891 | $7,315 | 4.79 % | $-18,212 | | | | | | News Article | History of Johnsonfamily Funds Inc - Johnsonfamily Large Cap Value Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Managers Trust I - Managers Fremont Global Fund | Global Flex Port | 11,800 | No Change | 0 | 0 % | $467,634 | $490,054 | $22,420 | 4.79 % | $0 | | | | | | News Article | History of Managers Trust I - Managers Fremont Global Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Manning And Napier Fund Inc Ny - Technology Series | Science & Tech | 18,445 | New Holding | 18,445 | 100 % | $730,975 | $766,021 | $35,046 | 4.79 % | $35,046 | | | | | | News Article | History of Manning And Napier Fund Inc Ny - Technology Series Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Morgan Stanley International Fund - None | Specialty & Misc | 68,080 | Sold Some | -58,346 | -46.15 % | $2,698,010 | $2,827,362 | $129,352 | 4.79 % | $-110,857 | | | | | | News Article | History of Morgan Stanley International Fund - None Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Oak Associates Funds - Live Oak Health Sciences Fund | Health/Biotech | 18,100 | No Change | 0 | 0 % | $717,303 | $751,693 | $34,390 | 4.79 % | $0 | | | | | | News Article | History of Oak Associates Funds - Live Oak Health Sciences Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Prudential World Fund Inc - Dryden International Equity Fund | International Multi-Cap Growth | 377,744 | New Holding | 377,744 | 100 % | $14,969,995 | $15,687,708 | $717,714 | 4.79 % | $717,714 | | | | | | News Article | History of Prudential World Fund Inc - Dryden International Equity Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Riversource International Managers Series Inc - Riversource International Aggressive Growth Fund | International Multi-Cap Growth | 258,113 | Sold Some | -13,600 | -5.00 % | $10,229,018 | $10,719,433 | $490,415 | 4.79 % | $-25,840 | | | | | | News Article | History of Riversource International Managers Series Inc - Riversource International Aggressive Growth Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Riversource International Managers Series Inc - Riversource International Equity Fund | International Multi-Cap Value | 606,500 | No Change | 0 | 0 % | $24,035,595 | $25,187,945 | $1,152,350 | 4.79 % | $0 | | | | | | News Article | History of Riversource International Managers Series Inc - Riversource International Equity Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Riversource International Series Inc - Riversource Disciplined International Equity Fund | Global Flex Port | 236,969 | Sold Some | -228,099 | -49.04 % | $9,391,081 | $9,841,323 | $450,241 | 4.79 % | $-433,388 | | | | | | News Article | History of Riversource International Series Inc - Riversource Disciplined International Equity Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Riversource International Series Inc - Riversource European Equity Fund | European Region | 46,531 | New Holding | 46,531 | 100 % | $1,844,024 | $1,932,432 | $88,409 | 4.79 % | $88,409 | | | | | | News Article | History of Riversource International Series Inc - Riversource European Equity Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Russell Investment Co - Emerging Markets Fund | Emerging Markets | 2,600,916 | Added More | 86,279 | 3.43 % | $103,074,301 | $108,016,041 | $4,941,740 | 4.79 % | $163,930 | | | | | | News Article | History of Russell Investment Co - Emerging Markets Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Schroder Capital Funds - Schroder International Alpha Fund | International Large-Cap Core | | Sold All | -1,862 | -100 % | | | | 4.79 % | $-3,538 | | | | | | News Article | History of Schroder Capital Funds - Schroder International Alpha Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Schroder Series Trust - Schroder International Diversified Value Fund | Multi-Cap Value | 2,064 | Added More | 202 | 10.84 % | $81,796 | $85,718 | $3,922 | 4.79 % | $384 | | | | | | News Article | History of Schroder Series Trust - Schroder International Diversified Value Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Target Portfolio Trust - International Equity | Global Flex Port | 30,700 | No Change | 0 | 0 % | $1,216,641 | $1,274,971 | $58,330 | 4.79 % | $0 | | | | | | News Article | History of Target Portfolio Trust - International Equity Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Van Kampen Trust Ii - Global Tactical Asset Allocation Fund | No Data | 3,953 | New Holding | 3,953 | 100 % | $156,657 | $164,168 | $7,511 | 4.79 % | $7,511 | | | | | | News Article | History of Van Kampen Trust Ii - Global Tactical Asset Allocation Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Vanguard International Equity Index Funds - Vanguard European Stock Index Fund | European Region | 8,708,631 | Sold Some | -4,256,080 | -32.82 % | $345,123,047 | $361,669,445 | $16,546,399 | 4.79 % | $-8,086,552 | | | | | | News Article | History of Vanguard International Equity Index Funds - Vanguard European Stock Index Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Vanguard International Equity Index Funds - Vanguard Ftse All-World Ex-Us Small-Cap Index Fund | No Data | 2,129,012 | Added More | 276,277 | 14.91 % | $84,372,746 | $88,417,868 | $4,045,123 | 4.79 % | $524,926 | | | | | | News Article | History of Vanguard International Equity Index Funds - Vanguard Ftse All-World Ex-Us Small-Cap Index Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-Q | Vanguard International Equity Index Funds - Vanguard Total World Stock Index Fund | No Data | 111,759 | Added More | 19,393 | 20.99 % | $4,429,009 | $4,641,351 | $212,342 | 4.79 % | $36,847 | | | | | | News Article | History of Vanguard International Equity Index Funds - Vanguard Total World Stock Index Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-29 | 2009-07-31 | N-CSRS | Vanguard Specialized Funds - Vanguard Health Care Fund | Health/Biotech | | Sold All | -1,942,381 | -100 % | | | | 4.79 % | $-3,690,524 | | | | | | News Article | History of Vanguard Specialized Funds - Vanguard Health Care Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-07-31 | N-Q | Aberdeen Funds - Aberdeen International Equity Fund | No Data | 10,814 | New Holding | 10,814 | 100 % | $428,991 | $449,105 | $20,114 | 4.68 % | $20,114 | | | | | | News Article | History of Aberdeen Funds - Aberdeen International Equity Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-07-31 | N-Q | Capital Income Builder Inc - Capital Income Builder Inc | Equity Income | 6,792,000 | No Change | 0 | 0 % | $269,438,640 | $282,071,760 | $12,633,120 | 4.68 % | $0 | | | | | | News Article | History of Capital Income Builder Inc - Capital Income Builder Inc Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-07-31 | N-Q | Federated Equity Funds - Federated Strategic Value Fund | Equity Income | 1,105,481 | Added More | 311,050 | 39.15 % | $43,854,431 | $45,910,626 | $2,056,195 | 4.68 % | $578,553 | | | | | | News Article | History of Federated Equity Funds - Federated Strategic Value Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-07-31 | N-Q | Idex Mutual Fds - Transamerica Thornburg International Value | No Data | 314,600 | New Holding | 314,600 | 100 % | $12,480,182 | $13,065,338 | $585,156 | 4.68 % | $585,156 | | | | | | News Article | History of Idex Mutual Fds - Transamerica Thornburg International Value Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-07-31 | N-Q | Idex Mutual Fds - Transamerica Wmc Emerging Markets | No Data | | Sold All | -314,600 | -100 % | | | | 4.68 % | $-585,156 | | | | | | News Article | History of Idex Mutual Fds - Transamerica Wmc Emerging Markets Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-07-31 | N-Q | Jpmorgan Trust I - Jpmorgan Intrepid European Fund | European Region | 184 | Added More | 6 | 3.37 % | $7,299 | $7,642 | $342 | 4.68 % | $11 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Intrepid European Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-07-31 | N-Q | Jpmorgan Trust I - Jpmorgan Intrepid International Fund | Global Flex Port | 240 | New Holding | 240 | 100 % | $9,521 | $9,967 | $446 | 4.68 % | $446 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Intrepid International Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-07-31 | N-Q | Jpmorgan Trust Ii - Jpmorgan International Equity Index Fund | Global Flex Port | 209 | New Holding | 209 | 100 % | $8,291 | $8,680 | $389 | 4.68 % | $389 | | | | | | News Article | History of Jpmorgan Trust Ii - Jpmorgan International Equity Index Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-07-31 | N-Q | Legg Mason Partners Equity Trust - Legg Mason Partners Equity Income Builder Fund | No Data | | Sold All | -6,500 | -100 % | | | | 4.68 % | $-12,090 | | | | | | News Article | History of Legg Mason Partners Equity Trust - Legg Mason Partners Equity Income Builder Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-07-31 | N-Q | Lord Abbett Securities Trust - Lord Abbett International Opportunities Fund | Global Flex Port | | Sold All | -48,000 | -100 % | | | | 4.68 % | $-89,280 | | | | | | News Article | History of Lord Abbett Securities Trust - Lord Abbett International Opportunities Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier International Equity Fund | International Multi-Cap Growth | 59,535 | Sold Some | -1,874 | -3.05 % | $2,361,753 | $2,472,489 | $110,735 | 4.68 % | $-3,486 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier International Equity Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-07-31 | N-Q | Morgan Stanley European Equity Fund Inc - None | Specialty & Misc | 415,624 | Sold Some | -19,464 | -4.47 % | $16,487,804 | $17,260,865 | $773,061 | 4.68 % | $-36,203 | | | | | | News Article | History of Morgan Stanley European Equity Fund Inc - None Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-07-31 | N-Q | Oppenheimer Master International Value Fund Llc - Oppenheimer Master International Value Fund Llc | International Multi-Cap Core | | Sold All | -26,182 | -100 % | | | | 4.68 % | $-48,699 | | | | | | News Article | History of Oppenheimer Master International Value Fund Llc - Oppenheimer Master International Value Fund Llc Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-07-31 | N-Q | Schwab Capital Trust - Laudus International Marketmasters Fund | Global Flex Port | 389,600 | Added More | 94,700 | 32.11 % | $15,455,432 | $16,180,088 | $724,656 | 4.68 % | $176,142 | | | | | | News Article | History of Schwab Capital Trust - Laudus International Marketmasters Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-07-31 | N-Q | Schwab Capital Trust - Schwab Fundamental International Large Company Index Fund | Large-Cap Core | 62,598 | Sold Some | -61,978 | -49.75 % | $2,483,263 | $2,599,695 | $116,432 | 4.68 % | $-115,279 | | | | | | News Article | History of Schwab Capital Trust - Schwab Fundamental International Large Company Index Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-07-31 | N-Q | Schwab Capital Trust - Schwab Health Care Fund | Health/Biotech | | Sold All | -127,000 | -100 % | | | | 4.68 % | $-236,220 | | | | | | News Article | History of Schwab Capital Trust - Schwab Health Care Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-07-31 | N-Q | Schwab Capital Trust - Schwab International Core Equity Fund | No Data | 29,460 | New Holding | 29,460 | 100 % | $1,168,678 | $1,223,474 | $54,796 | 4.68 % | $54,796 | | | | | | News Article | History of Schwab Capital Trust - Schwab International Core Equity Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-07-31 | N-Q | Schwab Capital Trust - Schwab International Index Fund | Global Flex Port | 832,673 | Sold Some | -24,926 | -2.90 % | $33,032,138 | $34,580,910 | $1,548,772 | 4.68 % | $-46,362 | | | | | | News Article | History of Schwab Capital Trust - Schwab International Index Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-07-31 | N-Q | Vanguard Star Funds - Vanguard Developed Markets Index Fund | International Multi-Cap Core | 1,496,350 | No Compare | | | $59,360,205 | $62,143,416 | $2,783,211 | 4.68 % | | | | | | | News Article | History of Vanguard Star Funds - Vanguard Developed Markets Index Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-07-31 | N-Q | Vanguard Star Funds - Vanguard Institutional Developed Markets Index Fund | Specialty & Misc | 2,694,033 | No Compare | | | $106,872,289 | $111,883,190 | $5,010,901 | 4.68 % | | | | | | | News Article | History of Vanguard Star Funds - Vanguard Institutional Developed Markets Index Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-07-31 | N-Q | Vanguard Star Funds - Vanguard Total International Stock Index Fund | International Multi-Cap Core | 9,809,408 | Added More | 180,028 | 1.86 % | $389,139,215 | $407,384,714 | $18,245,499 | 4.68 % | $334,852 | | | | | | News Article | History of Vanguard Star Funds - Vanguard Total International Stock Index Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-07-31 | N-Q | Vanguard Trustees Equity Fund - Vanguard International Value Fund | Multi-Cap Value | 4,420,880 | Sold Some | -224,100 | -4.82 % | $175,376,310 | $183,599,146 | $8,222,837 | 4.68 % | $-416,826 | | | | | | News Article | History of Vanguard Trustees Equity Fund - Vanguard International Value Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-07-31 | N-Q | Vanguard Windsor Funds - Vanguard Windsor Fund | Multi-Cap Value | 435,000 | Sold Some | -33,800 | -7.20 % | $17,256,450 | $18,065,550 | $809,100 | 4.68 % | $-62,868 | | | | | | News Article | History of Vanguard Windsor Funds - Vanguard Windsor Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-28 | 2009-06-30 | 13F-HR/A | Bridgewater Investment Management Llc | Institution | | Sold All | -495 | -100 % | | | | 4.68 % | $-921 | | | | | | News Article | History of Bridgewater Investment Management Llc Ownership Of Glaxosmithkline Plc |
| 2009-09-25 | 2009-07-31 | N-Q | Advantage Funds Inc - Global Alpha Fund | Global Flex Port | 13,116 | Sold Some | -5,489 | -29.50 % | $514,803 | $544,707 | $29,904 | 5.80 % | $-12,515 | | | | | | News Article | History of Advantage Funds Inc - Global Alpha Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-25 | 2009-07-31 | N-Q | Aston Funds - Astonneptune International Fund | Global Flex Port | 12,500 | No Change | 0 | 0 % | $490,625 | $519,125 | $28,500 | 5.80 % | $0 | | | | | | News Article | History of Aston Funds - Astonneptune International Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-25 | 2009-07-31 | N-Q | Direxion Shares Etf Trust - Direxion Daily Developed Markets Bull 3x Shares | No Data | 1,361 | Added More | 744 | 120.58 % | $53,419 | $56,522 | $3,103 | 5.80 % | $1,696 | | | | | | News Article | History of Direxion Shares Etf Trust - Direxion Daily Developed Markets Bull 3x Shares Ownership Of Glaxosmithkline Plc |
| 2009-09-25 | 2009-07-31 | N-Q | International Equity Portfolioma - International Equity Portfolio | Global Flex Port | 13,800 | No Change | 0 | 0 % | $541,650 | $573,114 | $31,464 | 5.80 % | $0 | | | | | | News Article | History of International Equity Portfolioma - International Equity Portfolio Ownership Of Glaxosmithkline Plc |
| 2009-09-25 | 2009-07-31 | N-Q | Mfs Government Limited Maturity Fund Ma - Mfs Diversified Target Return Fund | No Data | 20,510 | New Holding | 20,510 | 100 % | $805,018 | $851,780 | $46,763 | 5.80 % | $46,763 | | | | | | News Article | History of Mfs Government Limited Maturity Fund Ma - Mfs Diversified Target Return Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-25 | 2009-07-31 | N-Q | Mtb Group Of Funds - Mtb International Equity Fund | International Large-Cap Core | 20,700 | New Holding | 20,700 | 100 % | $812,475 | $859,671 | $47,196 | 5.80 % | $47,196 | | | | | | News Article | History of Mtb Group Of Funds - Mtb International Equity Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-25 | 2009-07-31 | N-Q | Tax Managed International Equity Portfolio - Tax Managed International Equity Portfolio | Global Flex Port | 84,700 | New Holding | 84,700 | 100 % | $3,324,475 | $3,517,591 | $193,116 | 5.80 % | $193,116 | | | | | | News Article | History of Tax Managed International Equity Portfolio - Tax Managed International Equity Portfolio Ownership Of Glaxosmithkline Plc |
| 2009-09-25 | 2009-07-31 | N-Q | Thrivent Mutual Funds - Thrivent Partner International Stock Fund | International Large-Cap Core | 418,870 | Sold Some | -1,526 | -0.36 % | $16,440,648 | $17,395,671 | $955,024 | 5.80 % | $-3,479 | | | | | | News Article | History of Thrivent Mutual Funds - Thrivent Partner International Stock Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-25 | 2009-07-31 | N-Q | Unified Series Trust - Marathon Value Portfolio | Multi-Cap Value | 10,000 | Sold Some | -12,360 | -55.27 % | $392,500 | $415,300 | $22,800 | 5.80 % | $-28,181 | | | | | | News Article | History of Unified Series Trust - Marathon Value Portfolio Ownership Of Glaxosmithkline Plc |
| 2009-09-25 | 2009-06-30 | 13F-HR/A | Kbc Group Nv | Institution | 3,300 | No Change | 0 | 0 % | $129,525 | $137,049 | $7,524 | 5.80 % | $0 | | | | | | News Article | History of Kbc Group Nv Ownership Of Glaxosmithkline Plc |
| 2009-09-24 | 2009-07-31 | N-Q | Currie Martin Business Trust - Mcbt Opportunistic Eafe Fund | Specialty & Misc | 89,724 | No Change | 0 | 0 % | $3,492,955 | $3,726,238 | $233,282 | 6.67 % | $0 | | | | | | News Article | History of Currie Martin Business Trust - Mcbt Opportunistic Eafe Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-24 | 2009-07-31 | N-Q | Dreyfus Index Funds Inc - Dreyfus International Stock Index Fund | International Multi-Cap Core | 279,153 | Sold Some | -16,030 | -5.43 % | $10,867,426 | $11,593,224 | $725,798 | 6.67 % | $-41,678 | | | | | | News Article | History of Dreyfus Index Funds Inc - Dreyfus International Stock Index Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-24 | 2009-07-31 | N-Q | Forum Funds - Shaker Fund | Specialty & Misc | | Sold All | -54,700 | -100 % | | | | 6.67 % | $-142,220 | | | | | | News Article | History of Forum Funds - Shaker Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-24 | 2009-07-31 | N-Q | Gartmore Mutual Funds - Nationwide International Value Fund | No Data | 135,100 | New Holding | 135,100 | 100 % | $5,259,443 | $5,610,703 | $351,260 | 6.67 % | $351,260 | | | | | | News Article | History of Gartmore Mutual Funds - Nationwide International Value Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-24 | 2009-07-31 | N-Q | Mfs Series Trust Vi - Mfs Global Equity Fund | Global Flex Port | 94,900 | Sold Some | -24,430 | -20.47 % | $3,694,457 | $3,941,197 | $246,740 | 6.67 % | $-63,518 | | | | | | News Article | History of Mfs Series Trust Vi - Mfs Global Equity Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-24 | 2009-07-31 | N-Q | Mfs Series Trust Vi - Mfs Global Total Return Fund | Global Flex Port | 316,400 | Added More | 81,600 | 34.75 % | $12,317,452 | $13,140,092 | $822,640 | 6.67 % | $212,160 | | | | | | News Article | History of Mfs Series Trust Vi - Mfs Global Total Return Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-24 | 2009-07-31 | N-Q | Nationwide Mutual Funds - Nationwide International Index Fund | Global Flex Port | | Sold All | -865,265 | -100 % | | | | 6.67 % | $-2,249,689 | | | | | | News Article | History of Nationwide Mutual Funds - Nationwide International Index Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-24 | 2009-07-31 | N-Q | Primecap Odyssey Funds - Primecap Odyssey Growth Fund | Multi-Cap Core | 88,800 | New Holding | 88,800 | 100 % | $3,456,984 | $3,687,864 | $230,880 | 6.67 % | $230,880 | | | | | | News Article | History of Primecap Odyssey Funds - Primecap Odyssey Growth Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-24 | 2009-07-31 | N-Q | Primecap Odyssey Funds - Primecap Odyssey Stock Fund | Multi-Cap Core | 79,100 | New Holding | 79,100 | 100 % | $3,079,363 | $3,285,023 | $205,660 | 6.67 % | $205,660 | | | | | | News Article | History of Primecap Odyssey Funds - Primecap Odyssey Stock Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-24 | 2009-07-31 | N-Q | Strategic Funds Inc - Systematic International Equity Fund | Global Flex Port | 2,547 | Sold Some | -3,652 | -58.91 % | $99,155 | $105,777 | $6,622 | 6.67 % | $-9,495 | | | | | | News Article | History of Strategic Funds Inc - Systematic International Equity Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-24 | 2009-06-30 | 13F-HR/A | Credit Agricole S A | Institution | 120 | Sold Some | -1,080 | -90.00 % | $4,672 | $4,984 | $312 | 6.67 % | $-2,808 | | | | | | News Article | History of Credit Agricole S A Ownership Of Glaxosmithkline Plc |
| 2009-09-23 | 2009-07-31 | N-Q | Dreman Contrarian Funds - Dreman Contrarian International Value Fund | No Data | 67 | Sold Some | -7 | -9.45 % | $2,655 | $2,783 | $128 | 4.82 % | $-13 | | | | | | News Article | History of Dreman Contrarian Funds - Dreman Contrarian International Value Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-23 | 2009-07-31 | N-Q | Dreyfus Laurel Funds Trust - Dreyfus Premier Equity Income Fund | Equity Income | 6,133 | New Holding | 6,133 | 100 % | $242,989 | $254,703 | $11,714 | 4.82 % | $11,714 | | | | | | News Article | History of Dreyfus Laurel Funds Trust - Dreyfus Premier Equity Income Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-23 | 2009-07-31 | N-Q | Ing Mayflower Trust - Ing International Value Fund | Multi-Cap Value | 1,875,980 | Added More | 8,600 | 0.46 % | $74,326,328 | $77,909,449 | $3,583,122 | 4.82 % | $16,426 | | | | | | News Article | History of Ing Mayflower Trust - Ing International Value Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-23 | 2009-07-31 | N-Q | Ing Mutual Funds - Ing Foreign Fund | International Multi-Cap Core | 172,023 | Added More | 128,725 | 297.30 % | $6,815,551 | $7,144,115 | $328,564 | 4.82 % | $245,865 | | | | | | News Article | History of Ing Mutual Funds - Ing Foreign Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-23 | 2009-07-31 | N-Q | Ing Mutual Funds - Ing Global Equity Dividend Fund | Global Multi-Cap Value | 69,620 | New Holding | 69,620 | 100 % | $2,758,344 | $2,891,319 | $132,974 | 4.82 % | $132,974 | | | | | | News Article | History of Ing Mutual Funds - Ing Global Equity Dividend Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-23 | 2009-07-31 | N-Q | Ing Mutual Funds - Ing International Equity Dividend Fund | Global Flex Port | 19,476 | New Holding | 19,476 | 100 % | $771,639 | $808,838 | $37,199 | 4.82 % | $37,199 | | | | | | News Article | History of Ing Mutual Funds - Ing International Equity Dividend Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-23 | 2009-07-31 | N-Q | Steward Funds Inc - International Equity Fund | International Large-Cap Value | 58,400 | Sold Some | -420 | -0.71 % | $2,313,808 | $2,425,352 | $111,544 | 4.82 % | $-802 | | | | | | News Article | History of Steward Funds Inc - International Equity Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-22 | 2009-07-31 | N-Q | Dreyfus Opportunity Funds - Dreyfus Global Sustainability Fund | No Data | 8,561 | No Change | 0 | 0 % | $339,016 | $355,538 | $16,523 | 4.87 % | $0 | | | | | | News Article | History of Dreyfus Opportunity Funds - Dreyfus Global Sustainability Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-21 | 2009-06-30 | 13F-HR/A | Eaton Vance Management | Institution | 793,066 | New Holding | 793,066 | 100 % | $31,175,424 | $32,936,031 | $1,760,607 | 5.64 % | $1,760,607 | | | | | | News Article | History of Eaton Vance Management Ownership Of Glaxosmithkline Plc |
| 2009-09-21 | 2009-06-30 | 13F-HR/A | Eaton Vance Management | Institution | 749,624 | New Holding | 749,624 | 100 % | $29,467,719 | $31,131,885 | $1,664,165 | 5.64 % | $1,664,165 | | | | | | News Article | History of Eaton Vance Management Ownership Of Glaxosmithkline Plc |
| 2009-09-21 | 2008-12-31 | N-Q/A | Brandes Investment Trust - Brandes Institutional Global Equity Fund | No Data | 20,400 | No Compare | | | $801,924 | $847,212 | $45,288 | 5.64 % | | | | | | | News Article | History of Brandes Investment Trust - Brandes Institutional Global Equity Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-21 | 2008-12-31 | N-Q/A | Brandes Investment Trust - Brandes Institutional International Equity Fund | Global Flex Port | 1,044,720 | New Holding | 1,044,720 | 100 % | $41,067,943 | $43,387,222 | $2,319,278 | 5.64 % | $2,319,278 | | | | | | News Article | History of Brandes Investment Trust - Brandes Institutional International Equity Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-18 | 2009-03-31 | N-CSRS/A | Brandes Investment Trust - Brandes Institutional Enhanced Income Fund | No Data | | Sold All | -3,500 | -100 % | | | | 6.21 % | $-8,505 | | | | | | News Article | History of Brandes Investment Trust - Brandes Institutional Enhanced Income Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-18 | 2009-03-31 | N-CSRS/A | Brandes Investment Trust - Brandes Institutional Global Equity Fund | No Data | 20,400 | No Change | 0 | 0 % | $797,640 | $847,212 | $49,572 | 6.21 % | $0 | | | | | | News Article | History of Brandes Investment Trust - Brandes Institutional Global Equity Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-18 | 2009-03-31 | N-CSRS/A | Brandes Investment Trust - Brandes Institutional International Equity Fund | Global Flex Port | 955,520 | Sold Some | -89,200 | -8.53 % | $37,360,832 | $39,682,746 | $2,321,914 | 6.21 % | $-216,756 | | | | | | News Article | History of Brandes Investment Trust - Brandes Institutional International Equity Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-17 | 2009-06-30 | 13F-HR/A | Delaware Management Business Trust | Institution | 5,616,328 | Sold Some | -268,231 | -4.55 % | $218,250,506 | $233,246,102 | $14,995,596 | 6.87 % | $-716,177 | | | | | | News Article | History of Delaware Management Business Trust Ownership Of Glaxosmithkline Plc |
| 2009-09-16 | 2009-06-30 | 13F-HR/A | Kcm Investment Advisors | Institution | 15,742 | Sold Some | -1,369 | -8.00 % | $612,836 | $653,765 | $40,929 | 6.67 % | $-3,559 | | | | | | News Article | History of Kcm Investment Advisors Ownership Of Glaxosmithkline Plc |
| 2009-09-15 | 2008-03-31 | 13F-HR/A | Segall Bryant And Hamill | Institution | 11,323 | Sold Some | -370 | -3.16 % | $438,879 | $470,244 | $31,365 | 7.14 % | $-1,025 | | | | | | News Article | History of Segall Bryant And Hamill Ownership Of Glaxosmithkline Plc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 20,335 | Sold Some | -1,830 | -8.25 % | $800,996 | $844,513 | $43,517 | 5.43 % | $-3,916 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Glaxosmithkline Plc |
| 2009-09-10 | 2009-06-30 | N-Q/A | Optimum Fund Trust - Optimum International Fund | Global Flex Port | 184,482 | New Holding | 184,482 | 100 % | $7,287,039 | $7,661,537 | $374,498 | 5.13 % | $374,498 | | | | | | News Article | History of Optimum Fund Trust - Optimum International Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-10 | 2009-06-30 | N-Q/A | Optimum Fund Trust - Optimum Large Cap Value Fund | Large-Cap Value | | Sold All | -89,570 | -100 % | | | | 5.13 % | $-181,827 | | | | | | News Article | History of Optimum Fund Trust - Optimum Large Cap Value Fund Ownership Of Glaxosmithkline Plc |
| 2009-09-10 | 2009-06-30 | 13F-HR/A | Veritable L P | Institution | 12,568 | Added More | 640 | 5.36 % | $496,436 | $521,949 | $25,513 | 5.13 % | $1,299 | | | | | | News Article | |
RSS feed for GSK